<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter" dtd-version="1.2" xml:lang="en">
    <front>
        <journal-meta>
            <journal-id journal-id-type="pmc">Gates Open Res</journal-id>
            <journal-title-group>
                <journal-title>Gates Open Research</journal-title>
            </journal-title-group>
            <issn pub-type="epub">2572-4754</issn>
            <publisher>
                <publisher-name>F1000 Research Limited</publisher-name>
                <publisher-loc>London, UK</publisher-loc>
            </publisher>
        </journal-meta>
        <article-meta>
            <article-id pub-id-type="doi">10.12688/gatesopenres.13042.1</article-id>
            <article-categories>
                <subj-group subj-group-type="heading">
                    <subject>Open Letter</subject>
                </subj-group>
                <subj-group>
                    <subject>Articles</subject>
                </subj-group>
            </article-categories>
            <title-group>
                <article-title>Community Inclusion in PrEP Demonstration Projects: Lessons for Scaling Up</article-title>
                <fn-group content-type="pub-status">
                    <fn>
                        <p>[version 1; peer review: 2 approved with reservations, 1 not approved]</p>
                    </fn>
                </fn-group>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author" corresp="yes" equal-contrib="yes">
                    <name>
                        <surname>Reza-Paul</surname>
                        <given-names>Sushena</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0000-0003-2716-1691</uri>
                    <xref ref-type="corresp" rid="c1">a</xref>
                    <xref ref-type="aff" rid="a1">1</xref>
                    <xref ref-type="aff" rid="a2">2</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no" equal-contrib="yes">
                    <name>
                        <surname>Lazarus</surname>
                        <given-names>Lisa</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0000-0002-7673-4671</uri>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Jana</surname>
                        <given-names>Smarajit</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a3">3</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Ray</surname>
                        <given-names>Protim</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a3">3</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Mugo</surname>
                        <given-names>Nelly</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a4">4</xref>
                    <xref ref-type="aff" rid="a5">5</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Ngure</surname>
                        <given-names>Kenneth</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0000-0002-8062-0933</uri>
                    <xref ref-type="aff" rid="a6">6</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Folayan</surname>
                        <given-names>Morenike Oluwatoyin</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0000-0002-9008-7730</uri>
                    <xref ref-type="aff" rid="a7">7</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Durueke</surname>
                        <given-names>Florita</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a8">8</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Idoko</surname>
                        <given-names>John</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a9">9</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>B&#x00e9;hanzin</surname>
                        <given-names>Luc</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a10">10</xref>
                    <xref ref-type="aff" rid="a11">11</xref>
                    <xref ref-type="aff" rid="a12">12</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Alary</surname>
                        <given-names>Michel</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0000-0002-0246-4429</uri>
                    <xref ref-type="aff" rid="a10">10</xref>
                    <xref ref-type="aff" rid="a13">13</xref>
                    <xref ref-type="aff" rid="a14">14</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Gueye</surname>
                        <given-names>Daouda</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a15">15</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Sarr</surname>
                        <given-names>Moussa</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a16">16</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Mukoma</surname>
                        <given-names>Wanjiru</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a17">17</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Kyongo</surname>
                        <given-names>Jordan K.</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a17">17</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Bothma</surname>
                        <given-names>Rutendo</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a18">18</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Eakle</surname>
                        <given-names>Robyn</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a18">18</xref>
                    <xref ref-type="aff" rid="a19">19</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Dallabetta</surname>
                        <given-names>Gina</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a20">20</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Presley</surname>
                        <given-names>Josie</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a21">21</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Lorway</surname>
                        <given-names>Robert</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <aff id="a1">
                    <label>1</label>Centre for Global Public Health, Rady Faculty of Health Sciences, Community Health Sciences, University of Manitoba, Winnipeg, Canada</aff>
                <aff id="a2">
                    <label>2</label>Ashodaya Samithi, Mysore, India</aff>
                <aff id="a3">
                    <label>3</label>Durbar Mahila Samanawaya Committee, Kolkata, India</aff>
                <aff id="a4">
                    <label>4</label>Center for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya</aff>
                <aff id="a5">
                    <label>5</label>Department of Global Health, University of Washington, Seattle, USA</aff>
                <aff id="a6">
                    <label>6</label>Department of Community Health, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya</aff>
                <aff id="a7">
                    <label>7</label>Department of Child Dental Health, Obafemi Awolowo University, Ile-Ife, Nigeria</aff>
                <aff id="a8">
                    <label>8</label>New HIV Vaccine and Microbicide Advocacy Society, Lagos, Nigeria</aff>
                <aff id="a9">
                    <label>9</label>Department of Medicine, University of Jos, Jos, Nigeria</aff>
                <aff id="a10">
                    <label>10</label>Centre de recherche du CHU de Qu&#x00e9;bec, Universit&#x00e9; Laval, Quebec, Canada</aff>
                <aff id="a11">
                    <label>11</label>Dispensaire IST, Centre de sant&#x00e9; communal de Cotonou 1, Cotonou, Benin</aff>
                <aff id="a12">
                    <label>12</label>&#x00c9;cole Nationale de Formation des Techniciens Sup&#x00e9;rieurs en Sant&#x00e9; Publique et en Surveillance &#x00c9;pid&#x00e9;miologique, Universit&#x00e9; de Parakou, Parakou, Benin</aff>
                <aff id="a13">
                    <label>13</label>D&#x00e9;partement de m&#x00e9;decine sociale et pr&#x00e9;ventive, Universit&#x00e9; Laval, Quebec, Canada</aff>
                <aff id="a14">
                    <label>14</label>Institut national de sant&#x00e9; publique du Qu&#x00e9;bec, Quebec, Canada</aff>
                <aff id="a15">
                    <label>15</label>Institut de Recherche en Sant&#x00e9;, de Surveillance Epid&#x00e9;miologique et de Formation (IRESSEF), Dakar, Senegal</aff>
                <aff id="a16">
                    <label>16</label>Westat, Inc, Rockville, USA</aff>
                <aff id="a17">
                    <label>17</label>LVCT Health, Nairobi, Kenya</aff>
                <aff id="a18">
                    <label>18</label>Wits Reproductive Health and HIV Institute (WRHI), Johannesburg, South Africa</aff>
                <aff id="a19">
                    <label>19</label>Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK</aff>
                <aff id="a20">
                    <label>20</label>Bill &amp; Melinda Gates Foundation, Washington, USA</aff>
                <aff id="a21">
                    <label>21</label>Bill &amp; Melinda Gates Foundation, Seattle, USA</aff>
            </contrib-group>
            <author-notes>
                <corresp id="c1">
                    <label>a</label>
                    <email xlink:href="mailto:sushenar@gmail.com">sushenar@gmail.com</email>
                </corresp>
                <fn id="fn1">
                    <p>*Joint first authors</p>
                </fn>
                <fn fn-type="conflict">
                    <p>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>5</day>
                <month>7</month>
                <year>2019</year>
            </pub-date>
            <pub-date pub-type="collection">
                <year>2019</year>
            </pub-date>
            <volume>3</volume>
            <elocation-id>1504</elocation-id>
            <history>
                <date date-type="accepted">
                    <day>24</day>
                    <month>6</month>
                    <year>2019</year>
                </date>
            </history>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2019 Reza-Paul S et al.</copyright-statement>
                <copyright-year>2019</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <self-uri content-type="pdf" xlink:href="https://gatesopenresearch.org/articles/3-1504/pdf"/>
            <abstract>
                <p>Pre-exposure prophylaxis (PrEP) has emerged as a new HIV prevention strategy. A series of demonstration projects were conducted to explore the use of PrEP outside of clinical trial settings. Learning from the failures in community consultation and involvement in early oral tenofovir trials, these PrEP projects attempted to better engage communities and create spaces for community involvement in the planning and roll out of these projects. We briefly describe the community engagement strategies employed by seven Bill Melinda Gates Foundation-funded PrEP demonstration projects and the lessons these projects offer for community engagement in PrEP implementation.</p>
            </abstract>
            <kwd-group kwd-group-type="author">
                <kwd>pre-exposure prophylaxis</kwd>
                <kwd>demonstration projects</kwd>
                <kwd>HIV</kwd>
                <kwd>prevention</kwd>
                <kwd>sex work</kwd>
                <kwd>serodiscordant couples</kwd>
            </kwd-group>
            <funding-group>
                <award-group id="fund-1" xlink:href="http://dx.doi.org/10.13039/100000865">
                    <funding-source>Gates Foundation</funding-source>
                    <award-id>OPP1104917</award-id>
                    <award-id>OPP1084414</award-id>
                    <award-id>OPP1098973</award-id>
                    <award-id>OPP1104919</award-id>
                    <award-id>OPP1056051</award-id>
                    <award-id>OPP1084416</award-id>
                </award-group>
                <award-group id="fund-2" xlink:href="http://www.gatesfoundation.org">
                    <funding-source>Gates Foundation</funding-source>
                    <award-id>OPP1108606</award-id>
                </award-group>
                <funding-statement>This work was supported by the Gates Foundation (University of Manitoba: OPP1108606; University of Washington Foundation: OPP1056051, National Agency for the Control of HIV and AIDS: OPP1104917, Wits Health Consortium: OPP1084416, CHU de Quebec: OPP1098973, Reseau Africain de Recherche sur le SIDA: OPP1084414, LVCT Health: OPP1104919).</funding-statement>
            </funding-group>
        </article-meta>
    </front>
    <body>
        <sec>
            <title>Background</title>
            <p>Pre-exposure prophylaxis (PrEP) is a new HIV prevention intervention for people who consider themselves at risk of acquiring HIV
                <sup>
                    <xref ref-type="bibr" rid="ref-1">1</xref>,
                    <xref ref-type="bibr" rid="ref-2">2</xref>
                </sup>. Current protocols and guidelines outline PrEP use as the intake of a daily pill (the combination of the antiretroviral therapies tenofovir and emtricitabine)
                <sup>
                    <xref ref-type="bibr" rid="ref-1">1</xref>
                </sup>. In September 2015, the World Health Organization (WHO) recommended that people at &#x201c;substantial risk&#x201d; of HIV infection have access to PrEP as part of comprehensive HIV prevention strategies
                <sup>
                    <xref ref-type="bibr" rid="ref-3">3</xref>
                </sup>.</p>
            <p>A number of randomized control trials have demonstrated clinical efficacy of PrEP
                <sup>
                    <xref ref-type="bibr" rid="ref-4">4</xref>&#x2013;
                    <xref ref-type="bibr" rid="ref-11">11</xref>
                </sup>. However, early oral tenofovir trials among marginalized communities, including in Cambodia, Cameroon, Nigeria, and Malawi among female sex workers (FSWs) and in Thailand among people who inject drugs, drew international attention with concerns over ethical violations in research practices
                <sup>
                    <xref ref-type="bibr" rid="ref-12">12</xref>,
                    <xref ref-type="bibr" rid="ref-13">13</xref>
                </sup>. Organized community action led to a halt of the trials in Cambodia and Cameroon
                <sup>
                    <xref ref-type="bibr" rid="ref-12">12</xref>
                </sup>, and a failure to start trials in Malawi
                <sup>
                    <xref ref-type="bibr" rid="ref-14">14</xref>
                </sup>. Although significant concerns were raised about the Thai trial, it ultimately proceeded
                <sup>
                    <xref ref-type="bibr" rid="ref-15">15</xref>
                </sup>, while the trial in Nigeria was discontinued by the research team based on non-protocol adherence
                <sup>
                    <xref ref-type="bibr" rid="ref-16">16</xref>
                </sup>.</p>
            <p>The community actions articulated that each of these trials was unethically conducted on the basis of not collaborating sufficiently with communities, providing selective information about potential adverse effects, and being unwilling to provide comprehensive health insurance and care for participants
                <sup>
                    <xref ref-type="bibr" rid="ref-12">12</xref>,
                    <xref ref-type="bibr" rid="ref-13">13</xref>
                </sup>. In order to find ways to move towards a more collaborative approach to biomedical HIV prevention research, a series of consultations following these study closures led to the creation of the 
                <italic toggle="yes">Good Participatory Practice: Guidelines for biomedical HIV prevention trials</italic>
                <sup>
                    <xref ref-type="bibr" rid="ref-17">17</xref>
                </sup>. These guidelines, prepared by UNAIDS and AIDS Vaccine Advocacy Coalition (AVAC), highlight community engagement in biomedical HIV prevention clinical trials as an ethical imperative. This was further stressed in an additional guidance note prepared by UNAIDS and the World Health Organization on 
                <italic toggle="yes">Ethical considerations in biomedical HIV prevention trials</italic>
                <sup>
                    <xref ref-type="bibr" rid="ref-18">18</xref>
                </sup>.</p>
            <p>These guidelines and the lessons learned from the initial controversies paved the way for more inclusive research practices. PrEP clinical trials and demonstration projects designed and implemented after these controversies were more proactive in their community engagement practices, engaging communities and creating spaces for community participation from planning through implementation of these projects. With confirmation of PrEP efficacy, the WHO called for implementation studies to inform product effectiveness and implementation. The Bill and Melinda Gates Foundation (BMGF) funded several demonstration projects with the aim of providing data on the implementation of PrEP in a diverse range of settings and populations. The aim of this paper is to articulate the community engagement practices implemented in seven BMGF-funded demonstration projects (listed in 
                <xref ref-type="table" rid="T1">Table 1</xref>). We describe the use of various community engagement strategies and engagement with a wide range of stakeholders in a diverse range of settings and populations.</p>
            <table-wrap id="T1" orientation="portrait" position="anchor">
                <label>Table 1. </label>
                <caption>
                    <title>List of PrEP Demonstration Projects funded by the Bill and Melinda Gates Foundation.</title>
                </caption>
                <table content-type="article-table" frame="hsides">
                    <thead>
                        <tr>
                            <th align="left" colspan="1" rowspan="1" valign="top">Study Name</th>
                            <th align="left" colspan="1" rowspan="1" valign="top">City, Country</th>
                            <th align="left" colspan="1" rowspan="1" valign="top">Population</th>
                            <th align="left" colspan="1" rowspan="1" valign="top">Implementer</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">The Partners Demonstration Project: Kenya and
                                <break/>Uganda</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">Kenya: Thika &amp;
                                <break/>Kisumu,
                                <break/>Uganda: Kampala &amp;
                                <break/>Kabwohe </td>
                            <td align="left" colspan="1" rowspan="1" valign="top">HIV-1 serodiscordant
                                <break/>couples</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">Kenya Medical Research Institute
                                <break/>(KEMRI),Nairobi, Kenya
                                <break/>Partners in Health Research and
                                <break/>Development (KEMRI),Thika
                                <break/>Infectious Diseases Institute (IDI),
                                <break/>Makerere University, Kampala,
                                <break/>Uganda
                                <break/>Clinical Research Center, Kabwohe,
                                <break/>Uganda</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">A demonstration project of antiretroviral-based
                                <break/>HIV prevention among HIV-1 sero-discordant
                                <break/>couples in Nigeria</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">Nigeria</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">HIV-1 serodiscordant
                                <break/>couples</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">The New HIV Vaccine and
                                <break/>Microbicide Advocacy Society
                                <break/>(NHVMAS) on behalf of the National
                                <break/>Agency for the Control of AIDS</td>
                        </tr>
                        <tr>
                            <th align="left" colspan="1" rowspan="1" valign="top">Study Name</th>
                            <th align="left" colspan="1" rowspan="1" valign="top">City, Country</th>
                            <th align="left" colspan="1" rowspan="1" valign="top">Population</th>
                            <th align="left" colspan="1" rowspan="1" valign="top">Implementer</th>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Early antiretroviral therapy and pre-exposure
                                <break/>prophylaxis for HIV prevention among female sex
                                <break/>workers in Benin, West Africa</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">Cotonou city, Benin</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">Female sex workers</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">CHU de Qu&#x00e9;bec &#x2013; Universit&#x00e9; Laval</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">A demonstration HIV pre-exposure prophylaxis
                                <break/>(PrEP) project with FTC/TDF among female sex
                                <break/>workers in Dakar, Senegal</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">Dakar, Senegal</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">Female sex workers</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">IRESSEF/WESTAT</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">The IPCP (Introducing PrEP into HIV Combination
                                <break/>Prevention) Project: Kenya</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">Nairobi, Kisumu and
                                <break/>Homabay, Kenya</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">Female sex workers,
                                <break/>men who have sex with
                                <break/>men, young women</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">LVCT Health</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">The treatment and prevention for female sex
                                <break/>workers (TAPS) demonstration project: South
                                <break/>Africa</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">Johannesburg and
                                <break/>Pretoria, South
                                <break/>Africa</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">Female sex workers</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">WITS Reproductive Health and HIV
                                <break/>Institute (Wits RHI)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Closing a critical HIV prevention gap:
                                <break/>demonstrating safety and effective delivery of
                                <break/>daily oral pre-exposure prophylaxis (PrEP) as part
                                <break/>of an HIV combination preventive intervention for
                                <break/>sex workers in Kolkata and Mysore-Mandya, India</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">Kolkata and
                                <break/>Mysore-Mandya,
                                <break/>India</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">Female sex workers</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">University of Manitoba
                                <break/>
                                <italic toggle="yes">DMSC
                                    <xref ref-type="other" rid="FN1">*</xref>
                                </italic>
                                <break/>
                                <italic toggle="yes">Ashodaya Samithi
                                    <xref ref-type="other" rid="FN1">*</xref>
                                </italic>
                            </td>
                        </tr>
                    </tbody>
                </table>
                <table-wrap-foot>
                    <fn>
                        <p id="FN1">
                            <italic toggle="yes">* Denotes community-based organization</italic>
                        </p>
                    </fn>
                </table-wrap-foot>
            </table-wrap>
        </sec>
        <sec>
            <title>Assessment of the research projects</title>
            <p>Throughout the course of the demonstration projects, BMGF conducted meetings involving implementers from the different project sites. The purpose of these meetings was to share project updates and facilitate cross-learning. The possibility of joint publications were discussed in these meetings and crystalized during a multi-site meeting in Benin in 2016. During this meeting, a joint manuscript was planned to capture the community engagement strategies employed in the various demonstration project sites.</p>
            <p>Members of each of the seven research projects completed an open-ended questionnaire exploring the objectives of their project, demand generation strategies, and role of the community in planning, recruitment, follow up, and retention. The first and second authors then conducted follow up phone interviews with a number of the sites to clarify their responses and gather more details about their work. A draft case study of each site was prepared, shared with the partners, and finalized with their inputs.</p>
        </sec>
        <sec>
            <title>Findings: The role of community in PrEP demonstration projects</title>
            <p>We present mini-case studies of each project that detail the overall role of community in various stages of the projects, challenges, and achievements related to community involvement. While we recognize that community is a loaded term that can mean different things in different contexts, for the purpose of the case studies presented, community includes the populations targeted by the demonstration projects (serodiscordant couples and sex workers) and the key stakeholders working with these populations.</p>
        </sec>
        <sec>
            <title>Demonstration projects involving serodiscordant couples</title>
            <sec>
                <title>The Partners Demonstration Project: Kenya and Uganda</title>
                <p>The Partners Demonstration Project explored delivery approaches among HIV-1 serodiscordant couples in Kenya and Uganda, with two sites in each country. PrEP was offered to the HIV-uninfected partner until the partner living with HIV had initiated and used ART for at least 6 months. The project ran from November 2012 to June 2016 and enrolled 1013 HIV serodiscordant couples across sites
                    <sup>
                        <xref ref-type="bibr" rid="ref-19">19</xref>&#x2013;
                        <xref ref-type="bibr" rid="ref-21">21</xref>
                    </sup>.</p>
                <p>The project&#x2019;s community strategy involved engagement with a wide range of stakeholders, community education on PrEP, and dispelling myths about HIV serodiscordance. Community entry was initiated through seeking approval from national and local government authorities in the Ministry of Health and Public Works, which was followed by meetings with lead members of community organizations (non-governmental, community-based, and faith-based), HIV serodiscordant couples support groups, and national and local health care authorities. The site projects instituted community advisory groups (CAGs), comprised of representatives of the above groups and members representing HIV serodiscordant couples. The CAGs acted as a link between the community and the project. They provided input on the study implementation, reviewed and advised the proposed recruitment approaches, and addressed community concerns. The research team worked with stakeholders to dispel myths, rumors, social taboos, concerns, and misconceptions related to HIV serodiscordance. </p>
                <p>Community health workers (CHWs) were the backbone to community entry. They conducted outreach and built trust about the project among the community. The project teams grouped CHWs by region and held training sessions on PrEP and HIV serodiscordance. During project implementation the CHWs discussed challenges faced by HIV serodiscordant couples and proposed strategies for recruitment. The HIV serodiscordant couple groups and other civil society organizations were agents who interacted with the local communities creating a receptive environment. Various leaders (opinion, religious, and others) supported couples HIV testing. Radio and TV stations were used to reach a wider audience with the benefits of couple testing and PrEP as a prevention option. There were regular engagements with various stakeholders on the safety and efficacy of PrEP. </p>
                <p>Recruitment strategies utilized a multi-prong approach that included capacity building of the HCWs, community education through posters and flyers that emphasized benefits of couples HIV counseling and testing (CHCT); community mobilization by peer recruiters and CHWs through the use of skits, music, puppets, and dances. Special attention was taken to develop messages for men who were generally more reluctant to go for testing. Recruitment strategies included referrals from existing voluntary counseling and testing centers, public promotion of CHCT by well-known individuals, community organizations (such as churches), and mobilization around events (for example, around Valentine&#x2019;s Day and market days). Discordant couples support groups used to meet regularly to promote further participation, retention, discuss challenges, and means of addressing them, including rumors.</p>
                <p>The Kenya Ministry of Health has since rolled out PrEP for persons at risk of HIV, including HIV-serodiscordant couples, as part of its combination strategy
                    <sup>
                        <xref ref-type="bibr" rid="ref-22">22</xref>
                    </sup>.</p>
            </sec>
        </sec>
        <sec>
            <title>The Nigeria PrEP Demonstration Project</title>
            <p>The Nigeria PrEP Demonstration Project aimed at providing PrEP to HIV-negative partners in HIV-1 serodiscordant relationships until the HIV-positive partner was virologically suppressed. It used community-designed models that recruited 345 HIV-1 serodiscordant coupled across three main sites and six satellite sites in Nigeria. The study took place between 2012&#x2013;2018 and was designed through stakeholder consultation that engaged HIV service providers, consumers, policymakers, as well as other key stakeholders in the design and implementation of the project. The project first had a roadmap developed through stakeholder engagement
                <sup>
                    <xref ref-type="bibr" rid="ref-23">23</xref>
                </sup>. The roadmap was divided into three phases. The first phase involved a modeling study to determine if PrEP would be of benefit to the national HIV prevention program
                <sup>
                    <xref ref-type="bibr" rid="ref-24">24</xref>
                </sup>. The second phase included formative research to help determine the study design and the study target population
                <sup>
                    <xref ref-type="bibr" rid="ref-25">25</xref>
                </sup>. The third phase rolled out the design and implementation of the main demonstration project.</p>
            <p>The main objective of the demonstration project was to determine the effectiveness of PrEP delivery models in reducing HIV transmission among HIV serodiscordant couples. The project also prioritized the formation of community engagement structures at the three sites. First, New HIV Vaccine and Microbicide Advocacy Society (NHVMAS) developed a protocol for its community engagement project in line with 
                <italic toggle="yes">Good Participatory Practice: Guidelines for biomedical HIV prevention trials</italic>
                <sup>
                    <xref ref-type="bibr" rid="ref-17">17</xref>
                </sup>. Next, it held a public engagement meeting with a wide range of stakeholders &#x2013; policymakers, HIV programmers, community advocates, traditional leaders, religious leaders, journalists, and researchers. The PrEP demonstration project was introduced to the community members, and decisions were collaboratively made on the community engagement structure, including the composition of the Community Advisory Board (CAB) and civil societies to conduct the public education program. Letters were sent to the identified organizations and institutions to be represented on the CAB. Monthly meetings were facilitated between the community stakeholders and the research team by NHVMAS. The boards had a standing operating procedure manual guiding their monthly meetings. Study staff participated in the monthly meetings in order to give updates on the project and to hear and learn from the CAB members about community concerns about the research.</p>
            <p>Representatives from the civil society were initially trained on the use of a developed and pilot-tested flipchart for educating the public about PrEP. They were also equipped with educational pouches that contained samples of biomedical HIV prevention tools discussed in the flipchart to show during public education programs. This included samples of PrEP. Monthly meetings were also held for the public educators to report back on targets reached during their public education programs, discuss questions asked and challenges faced during their public engagement. The issues were jointly resolved with NHVMAS.</p>
            <p>A quarterly research literacy capacity building training for CAB members and the civil society organization representatives was conducted at each of the research sites. A curriculum was developed for this educational program. Four two-day capacity building workshops were conducted at each of the study sites throughout the project. In addition, a social surveillance system was instituted by the project. Social surveillance was included in the study design to ensure semi-annual monitoring of individual, facility, and community concerns about the study. The surveillance was managed by social scientists located at each of the study sites and coordinated by the lead persons managed by the National Agency for the Control of AIDS (NACA). The results of their monitoring exercises were fed back in real time into the project implementation process.</p>
            <p>A media engagement project was conducted at one of the three sites. The aim was to assess the impact of public engagement through the use of the media on study participant recruitment and retention. Analysis showed that although the media engagement resulted in a significant increase in public inquiry at the study intervention site, it was not significantly associated with an increase in study participant recruitment or retention. The project did lead to an increase in awareness and public education about PrEP in Nigeria. Other community members, such as FSWs and men who have sex with men (MSM), took part in consultative meetings on how to maximize the study outcome to address PrEP needs. Stakeholders successfully mobilized and advocated for the inclusion of PrEP in national guidelines in 2016. Research findings were disseminated to community members at the annual civil society organization accountability forum in 2018.</p>
        </sec>
        <sec>
            <title>Demonstration projects involving sex workers</title>
            <sec>
                <title>Early antiretroviral therapy and PrEP for HIV prevention among FSWs: Benin, West Africa</title>
                <p>The CHU de Qu&#x00e9;bec &#x2013; Universit&#x00e9; Laval Research Centre has been working with FSW projects in Benin since 1992. The PrEP demonstration project was aimed at assessing the feasibility and usefulness of integrating treatment as prevention (TasP) and PrEP to the combination prevention package offered to sex workers in Benin. The project was initiated from the end of 2014 until December 2016 in Cotonou. After a community preparedness phase, 256 FSWs were recruited for PrEP. All participants were followed up for 12 months.</p>
                <p>During the community preparedness phase, community workers (CWs) worked with FSWs and provided information on the project in small groups and in one-on-one sessions. CWs were field workers who had at least 15 years of experience in working with sex workers (but were not sex workers themselves). CWs carried out these activities in two teams. Each team was responsible for covering one of the two zones forming the catchment area. This enabled the same CWs to closely follow up with participants and address their concerns throughout the study (screening, enrolment, and follow up). Before intervening in an area, CWs first contacted the owners or managers of the sex work sites to determine the most suitable timings for their interventions. They then provided background information on HIV and about the project. Information about the study was also shared with a sex worker organization (Association Solidarit&#x00e9;) to garner support and facilitate mobilization to participate in the study. The mobilization for screening was carried out in groups of 7&#x2013;10 followed by individual meetings. Simultaneously, peer educators (especially those working with project &#x00c9;quit&#x00e9; en sant&#x00e9;, another CHU de Qu&#x00e9;bec &#x2013; Universit&#x00e9; Laval-led HIV prevention project) also mobilized the FSWs who were part of their network.</p>
                <p>During community mobilization, coupons for screening visits were handed out to the women. Active tracking was carried out for those who missed appointments. The CWs reminded the women of the appointment on three occasions, one week, three days, and one day prior to the appointment, either by telephone or by meeting them at their residence, workplace, or place of their choice. In case of a missed screening visit, participants were contacted to see if they were still willing to participate in the study and were provided with a new appointment. Often peer educators also reminded the women of their appointments by repeatedly visiting them.</p>
                <p>Following the screening visit, an auxiliary nurse reviewed the recruitment and the CWs were responsible for contacting the participants to confirm the appointment. The CWs were also responsible for promoting adherence and informing the participants about side effects during their field visits for community-based distribution of condoms and PrEP and for locating women lost to follow up. They simultaneously addressed concerns in the community.</p>
                <p>Upon completion of the study, sex workers were involved in dissemination of the results. A dissemination workshop was conducted with various stakeholders including FSWs and policymakers. In the short-term following the workshop in May 2017, there was no government plan to scale up PrEP in Benin. However, it has now been possible to provide PrEP to the study participants who still requested it and the Benin Ministry of Health is now in the process of implementing PrEP access for key populations and serodiscordant couples.</p>
            </sec>
        </sec>
        <sec>
            <title>Senegal case study</title>
            <p>A PrEP demonstration project was conducted in Dakar, Senegal among FSWs. The project explored the feasibility of providing daily oral PrEP for 12 months to enrolled participants at four Ministry of Heath-run clinics. A total of 350 participants were screened during an accrual period of 3 months (from June 2015 to October 2015) and 267 eligible participants were enrolled.</p>
            <p>The community has been involved in all phases of the project. The planning phase occurred over 5 weeks in 2015. The feasibility study provided information regarding sex workers&#x2019; perceptions on PrEP, its acceptability, and strategies to resolve challenges, including stigma.</p>
            <p>Four peer educators per study site were recruited by the study team, in collaboration with local organizations working on HIV prevention and trained for the implementation phase. They were chosen based on their leadership within the sex worker community and their experience in HIV prevention efforts. Peer educators worked closely with the social workers at each of the study sites and facilitated recruitment and follow up. They also sensitized the health care staff on the needs of the community. They were tasked with identifying potential participants in the neighborhoods, provided them with information about PrEP, and referred interested participants to the nearest clinics where PrEP was provided. Social workers and midwives were responsible for informing sex workers about the study procedures. Peer educators played a key role designing communication strategies on PrEP. They were responsible for following up with participants in-person twice a week, along with phone calls, and home visits for those who missed appointments. During their interactions, they tried to find out the reasons for missed appointments, re-educated participants on PrEP, encouraged them to come in for routine clinic visits, and addressed issues related to stigma, family, and adherence. The peer educators who were taking PrEP became role models and shared their experiences with the participants. With time, participants were calling the free study phone number on their own to follow up on appointments.</p>
            <p>Preliminary findings and scale up strategies have been shared at a national scientific meeting organized by the Ministry of Health. Further dissemination is planned to advocate for the inclusion of PrEP as an HIV prevention option for the national program.</p>
        </sec>
        <sec>
            <title>The Introducing PrEP into HIV Combination Prevention (IPCP) Project: Kenya</title>
            <p>LVCT Health is an indigenous Kenyan non-governmental organization that provides HIV and sexual reproductive health services to MSM, FSWs, and young women (YW). This project aimed to demonstrate how daily oral PrEP can be delivered as part of an HIV combination prevention package among these three populations. Between August 2015 and October 2016, the project recruited 796 FSWs, 597 MSM, and 723 YW. Participants were offered daily oral PrEP and followed over a period of 12 months.</p>
            <p>Several community organizations assisted in this study but two key populations organizations, Bar Hostess Empowerment and Support Programme (BHESP) and Health Options for Young Men on HIV/AIDS/STI (HOYMAS) were direct implementing partners. Two representatives of these two organizations were co-investigators on the project. These organizations were involved in various stages of the project. During the project design, the peer-led organizations were involved in: the selection of the implementation sites; providing leadership on community education on combination HIV prevention and PrEP, sharing community perspectives on PrEP with the project team, ensuring community buy-in, mobilizing community for participation, advising on strategies to address emerging community concerns regarding PrEP, and the constitution of a CAB with members of various MSM and FSW organizations. BHESP and HOYMAS were also involved in the feasibility study that assessed willingness to take PrEP among the target populations
                <sup>
                    <xref ref-type="bibr" rid="ref-26">26</xref>
                </sup>.</p>
            <p>During implementation, the CAB supported different aspects of the project, such as project monitoring, PrEP advocacy at the community and national level, and results dissemination and discussion. At site level, community advisory committees were formed consisting of nominees from different MSM and FSW organizations. They held monthly meetings to develop and review demand generation strategies for PrEP, discuss adherence issues, develop materials on HIV prevention tailored to meet target group needs and strategies for addressing emerging community and user concerns. They acted as PrEP advocates to the communities they represented and also provided community feedback to the site in-charges where they were attached.</p>
            <p>Peer educators were trained on PrEP and used brochures and flyers to disseminate information to their communities. They played an important role in addressing concerns and tailoring messages. Peer educators met participants where they were available and came up with targeted approaches based on the different communities. Early adopters, known as &#x201c;guides&#x201d; or &#x201c;PrEP ambassadors&#x201d; also shared their experiences taking PrEP. Peer educators played a key role in retaining participants in the study and were responsible for checking in with participants who missed appointments to understand the reasons why and address them jointly with the health care workers at participating facilities. Regular meetings were held between peers and organizational staff to discuss this work. Support group meetings were held monthly and provided opportunities for participants to share challenges with PrEP and discuss potential solutions.</p>
            <p>At one point during implementation, young men in one of the urban sites stormed LVCT offices and demanded a stop of the project alluding that it was providing their YW a drug that would make them infertile. LVCT halted the project for a few days and used this time to engage the wider community including young men who were not a target population. The teams worked with the local village administrative chiefs, families, male opinion leaders, and partners of the participants, to increase awareness about PrEP and educate the wider community to support enrollment and retention. The project continued to keep community members aware of the progress and undertook regular community awareness activities such as utilizing the local area Chief&#x2019;s community meetings, participating in talk shows at the local radio station, and utilizing a community-level HIV prevention champions to talk about PrEP and the project.</p>
            <p>As PrEP is now available in public and community-based facilities in Kenya, LVCT Health and other implementing partners work with the Government to engage communities in demand generation, awareness creation, and adherence support during PrEP scale up. Community ambassadors continue to play a critical role in scaling up PrEP in Kenya.</p>
        </sec>
        <sec>
            <title>The Treatment And Prevention for Female Sex Workers (TAPS) Demonstration Project: South Africa</title>
            <p>The TAPS Demonstration Project was conducted by Wits RHI between March 2015 and July 2017, in Johannesburg and Pretoria, South Africa
                <sup>
                    <xref ref-type="bibr" rid="ref-27">27</xref>
                </sup>. FSWs from the surrounding sites were invited to participate. Post screening, eligible FSWs were either offered ART or PrEP along with the range of Wits RHI clinic services through their Sex Worker Project (SWP). Overall, 351 women were screened and 219 were enrolled for the PrEP arm of the study.</p>
            <p>Meetings with various stakeholders including community organizations, FSWs, and other stakeholders started in the summer of 2013
                <sup>
                    <xref ref-type="bibr" rid="ref-28">28</xref>
                </sup>. These meetings helped in designing the formative research, which then informed TAPS. A ten-person CAB, comprised of representatives from various organizations and two-to-three FSWs, was formed in 2014. The CAB meetings were used as a platform for identifying any training needs of CAB members, advising research staff on sex worker community norms and expectations, and creating a supportive environment for the project by raising awareness and dispelling myths/rumors about PrEP. CAB members also facilitated recruitment by identifying contacts. </p>
            <p>The TAPS study collaborated with the existing peer educators from the SWP who were instrumental in delivering education about PrEP by incorporating PrEP messages into their existing peer outreach activities, getting buy-in by the community, and identifying high-risk FSWs from their network. Peer educators were responsible for follow up. Little was known about PrEP at the start of the study, so a lot of initial work focused on demystifying PrEP, educating the community, and getting buy-in. Cards with the project details were used for recruitment. Recruitment was done during day and night, in streets, brothels, hotels, and clinics&#x2014;where peers would often accompany participants to their screening. During outreach, peer educators conducted education sessions and handed information materials to women including condom bags and discussed various issues that impacted them, such as police harassment, client abuse, violence, and STIs. Research staff attended these sessions to provide information about PrEP and respond to any questions raised. A mobile clinic service was established to access and create demand for sex workers who were based farther away from the clinics. These processes facilitated recruitment.</p>
            <p>The peer educators played a key role in supporting participants who missed follow up appointments, by addressing concerns such as side effects and challenges with partners. Peers were best able to draw on their own experiences when addressing concerns. During the study, several challenges emerged including xenophobic riots and police raids where many participants worked and lived. Engagement with sex worker advocacy groups supported the sex workers affected by these issues.</p>
            <p>An important outcome of the project was that the national program began initiating PrEP for sex workers in 11 clinics across South Africa even before the end of the study. This was largely possible due to the constant feedback and reporting to the National Department of Health from the research team regarding their learning and experiences on a rolling basis. Results and lessons learned from the TAPS project were used to develop the first set of national guidelines to include PrEP, which were initially focused on the rollout to sex workers
                <sup>
                    <xref ref-type="bibr" rid="ref-22">22</xref>
                </sup>.</p>
        </sec>
        <sec>
            <title>India: The Closing a Critical Prevention Gap project</title>
            <p>The Closing a Critical Prevention Gap project took place at two sites in India to evaluate PrEP delivery strategies, monitor adherence to and discontinuation of PrEP, and evaluate unintended consequences of the use of PrEP in these communities. The University of Manitoba, as the technical partner, supported two well-established community-based organizations that implemented demonstration projects in two distinctive settings.</p>
        </sec>
        <sec>
            <title>Durbar Mahila Samanwaya Committee (DMSC) case study: Kolkata, India</title>
            <p>Starting in 1992, the Sonagachi Project in Kolkata began providing HIV prevention services for FSWs. It soon grew into the Durbar Mahila Samanwaya Committee (DMSC), a community-owned sex work project of more than 60,000 FSWs. The PrEP demonstration project began by raising awareness on PrEP steered by the members of the DMSC along with the peer educators of the ongoing HIV intervention program. A feasibility study was conducted to identify possible enablers and barriers in taking PrEP. Screening for the demonstration project started in January 2016. A total of 843 FSWs were screened out of which 678 enrolled. Peer educators were trained to discuss condoms and PrEP as &#x201c;double protection&#x201d;. Based on the feasibility study, a potential participant list was created of women interested in PrEP and divided among the peer educators.</p>
            <p>Although women were interested in taking PrEP, during recruitment it was found that some madams (brokers) would not let them go through the screening process as it would waste a day of work. This reinforced the importance of working with other stakeholders, including pimps and boyfriends, in addition to madams. All stakeholders were provided with information on PrEP and how it prevents HIV and therefore helps maintain health, which then helps ensure the ability to keep working and earning. To create interest, the cultural team of DMSC performed street dramas in Sonagachi, to promote the effectiveness of PrEP as a combination HIV prevention tool.</p>
            <p>Peer educators played a vital role in walking participants through the screening and follow up. They would initially visit participants every day for the first 7 days to ensure daily intake and monitor side effects. Counselors and doctors also made home visits. Once adjusted to PrEP, peer educators started providing medicine weekly, fortnightly, and then monthly, following the first month clinical follow up. Telephone calls were also used to remind women of their follow up visits. Challenges to follow up included women leaving the area without notice. This was addressed by asking about upcoming travel plans and providing extra pills if travel was planned before the next refill date.</p>
            <p>There is a great demand among FSWs to continue PrEP post-demonstration project. Two thirds of the participants were able to continue PrEP after their exit from the study, due to a surplus in tablets, however this supply has since ended.</p>
        </sec>
        <sec>
            <title>Ashodaya Samithi case study: Mysore, India</title>
            <p>Ashodaya Samithi, a female, male, and transgender sex work collective, implemented the PrEP project in Mysore-Mandya. The project began with awareness sessions and a feasibility study, between December 2014 and May 2015
                <sup>
                    <xref ref-type="bibr" rid="ref-29">29</xref>
                </sup>. The demonstration project ran from March 2016 until February 2018. In total, 647 participants were enrolled after screening 707 FSWs.</p>
            <p>The sex work community played key roles in all phases of the design and implementation of the study. Numerous awareness sessions and small group discussions were held in the field to answer all questions about PrEP and understand community concerns. Discussions surrounded the need for PrEP, condom use, side effects, travel, and alcohol use. Community members expressed a great need for PrEP, especially in instances where they were unable to use condoms. </p>
            <p>Sex work community leaders volunteered to be the first participants, which built trust in the project. Leaders then went on to recruit and mobilize participants through their peer networks by acting as &#x201c;role models&#x201d; and sharing their personal testimonials taking PrEP. Sex work leaders living with HIV further supported the usefulness of PrEP and were involved in mobilization to ensure that the study did not create social divisions in the community between those living with HIV and those who were HIV negative. Rumors about PrEP and side effects were addressed by peers at the ground level. Attempts were made to address all concerns as they arose. Sex work leaders and the technical support team conducted sensitization sessions with the police to create an enabling environment for the project and help prevent disruptions in adherence due to raids and arrests. This helped in building community trust and buy-in. Similar sensitization sessions were held with boyfriends, clients, family, and brokers as they too played key roles in ensuring retention.</p>
            <p>The sites were divided into 10 clusters with 20 community mobilizers playing a key role in the recruitment and follow up of the participants. Following recruitment, mobilizers accompanied potential participants to screening visits. Negotiations took place with the lab for same-day test results as to not lose potential participants to follow up. Once enrolled, community mobilizers were responsible for following up with participants from their network to ensure delivery of medicine fortnightly, monitor adherence and routine quarterly clinic visits, and address any crises that may have arose. Daily check-ins provided opportunities to offer support for other health and social issues beyond PrEP to both participants taking PrEP and their wider networks.</p>
            <p>Press and electronic media coverage is being used to disseminate findings and to help advocate for PrEP as part of the national HIV prevention package in India.</p>
        </sec>
        <sec sec-type="discussion">
            <title>Discussions and lessons learned</title>
            <p>These case studies highlight the important role that community engagement played in the PrEP demonstration projects. As many countries are interested in initiating PrEP or scaling up PrEP access
                <sup>
                    <xref ref-type="bibr" rid="ref-22">22</xref>
                </sup>, it is important to understand the best ways to implement PrEP as part of combination HIV prevention. The case studies document various aspects of PrEP implementation, such as how to deliver PrEP and make it available and accessible to key populations. The processes documented in these case studies highlight the programmatic approaches undertaken among two major groups: serodiscordant couples and key population that includes FSWs, MSM, and YW. Although there were context specific considerations in the design of the interventions, there are some commonalities between projects that are important lessons for PrEP roll out.</p>
            <p>In the demonstration projects among serodiscordant couples, the community was broadly defined. It extended beyond the primary stakeholders, the HIV serodiscordant couples themselves, to include local leaders, religious leaders, and local community organizations. Key to initiating PrEP among serodiscordant couples is the promotion of couple testing. Mass media communication strategies that included the use of TV, radio, and street theatre, played an important role in promoting couples counseling and testing, and included targeted messages to men, who often show more reluctance to testing
                <sup>
                    <xref ref-type="bibr" rid="ref-30">30</xref>&#x2013;
                    <xref ref-type="bibr" rid="ref-32">32</xref>
                </sup>. Special attention needs to be provided to handle crises among couples that may arise because of serodiscordancy. Serodiscordant couples groups should play a critical role in providing this support, along with dispelling any myths/misconceptions about PrEP and offering adherence support. Simultaneously, capacity building for health care workers when planning PrEP access is also important
                <sup>
                    <xref ref-type="bibr" rid="ref-33">33</xref>
                </sup>. Thus, it is key to develop multi-pronged strategies of community engagement, capacity building, and mass media promotion to generate demand when implementing PrEP among serodiscordant couples.</p>
            <p>The demonstration projects documented the critical role of community, defined here mainly as female sex workers, men who have sex with men, and YW who are at risk of getting HIV, in different aspects of the project. It is important to understand that there are varying degrees of cohesion and community involvement, keeping in mind the local context. Despite this, there are several common areas of community engagement to highlight. Each of the locations have made sure that community leaders and peer educators have played a role in developing education materials and tools in promoting awareness and demand. As seen in the projects among serodiscordant couples, projects among sex workers also reached wider community stakeholders who could influence decisions around PrEP use and adherence, such as madams, boyfriends, clients, and the police, highlighting the need for community engagement beyond just the intended users of PrEP in order to create an enabling environment for PrEP use.</p>
            <p>Taking lessons from the proven strategies of peer-led outreach in HIV prevention and treatment programs
                <sup>
                    <xref ref-type="bibr" rid="ref-34">34</xref>&#x2013;
                    <xref ref-type="bibr" rid="ref-37">37</xref>
                </sup>, these studies highlight how communities play strategic roles ranging from demand generation, to PrEP distribution among their social networks, and ensuring follow up. Community leaders or peer educators were often the &#x201c;early adopters,&#x201d; who became &#x201c;role models&#x201d; in ensuring adherence. Some of these case studies highlight that the demonstration projects were steered and owned by the community through their community-based organizations. This points to the importance of providing sufficient resources to support community engagement in implementing PrEP projects.</p>
            <p>While the case studies presented here are limited in scope, they provide important insight into the ways that communities are engaged in PrEP demonstration projects globally. As each site developed contextually-specific approaches to rolling out their demonstration projects, comparison of the case studies could not be done. Yet, context-specific designs were important for the community engagement programs to be successful. Therefore, these studies provide important insights on ways to engage communities in biomedically-focused research and programs. More detailed findings from each site will be published separately.</p>
        </sec>
        <sec sec-type="conclusions">
            <title>Conclusion</title>
            <p>The WHO underpins the importance of PrEP as an HIV prevention option
                <sup>
                    <xref ref-type="bibr" rid="ref-3">3</xref>
                </sup> and the importance of community engagement in implementing PrEP
                <sup>
                    <xref ref-type="bibr" rid="ref-38">38</xref>
                </sup>. Several countries, such as Kenya and South Africa, have initiated PrEP scale-up post-demonstration projects. However, there is limited experience globally in providing PrEP outside the scope of clinical trials and demonstration projects. As further countries move forward with PrEP implementation, it is critical to understand how best to scale up PrEP in diverse settings. Community engagement has emerged as a critical factor for education, demand generation, dispelling rumors, and supporting adherence and follow up in the PrEP demonstration project case studies. The increasing global interest in PrEP necessitates the importance of understanding the best ways to implement PrEP in different settings as part of combination HIV prevention. PrEP as a biomedical solution has to have a huge buy-in by the community &#x2013; from its leadership to its larger networks who go on to become the users of this important prevention tool.</p>
        </sec>
        <sec>
            <title>Data availability</title>
            <p>No data are associated with this article.</p>
        </sec>
    </body>
    <back>
        <ack>
            <title>Acknowledgements</title>
            <p>We would sincerely like to thank all of the communities and participants who contributed to this research.</p>
        </ack>
        <ref-list>
            <ref id="ref-1">
                <label>1</label>
                <mixed-citation publication-type="journal">
                    <collab>CDC</collab>:
                    <article-title>Pre-Exposure Prophylaxis (PrEP) for HIV Prevention</article-title>.<year>2014</year>.
                    <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/hiv/pdf/prep_fact_sheet_final.pdf">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref-2">
                <label>2</label>
                <mixed-citation publication-type="journal">
                    <collab>World Health Organization</collab>:
                    <article-title>Guidance on oral pre-exposure prophylaxis (PrEP) for serodiscordant couples, men and transgender women who have sex with men at high risk of HIV: recommendations for use in the context of demonstration projects</article-title>.<year>2012</year>.
                    <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/iris/bitstream/handle/10665/75188/9789241503884_eng.pdf?sequence=1">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref-3">
                <label>3</label>
                <mixed-citation publication-type="journal">
                    <collab>World Health Organization</collab>:
                    <article-title>Pre-exposure prophylaxis</article-title>.<year>2015</year>.
                    <ext-link ext-link-type="uri" xlink:href="http://www.who.int/hiv/topics/prep/en/">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref-4">
                <label>4</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Baeten</surname>
                            <given-names>JM</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Donnell</surname>
                            <given-names>D</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ndase</surname>
                            <given-names>P</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.</article-title>
                    <source>

                        <italic toggle="yes">N Engl J Med.</italic>
</source>
                    <year>2012</year>;<volume>367</volume>(<issue>5</issue>):<fpage>399</fpage>&#x2013;<lpage>410</lpage>.
                    <pub-id pub-id-type="pmid">22784037</pub-id>
                    <pub-id pub-id-type="doi">10.1056/NEJMoa1108524</pub-id>
                    <pub-id pub-id-type="pmcid">3770474</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-5">
                <label>5</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Choopanya</surname>
                            <given-names>K</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Martin</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Suntharasamai</surname>
                            <given-names>P</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.</article-title>
                    <source>

                        <italic toggle="yes">Lancet.</italic>
</source>
                    <year>2013</year>;<volume>381</volume>(<issue>9883</issue>):<fpage>2083</fpage>&#x2013;<lpage>90</lpage>.
                    <pub-id pub-id-type="pmid">23769234</pub-id>
                    <pub-id pub-id-type="doi">10.1016/S0140-6736(13)61127-7</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-6">
                <label>6</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Grant</surname>
                            <given-names>RM</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Lama</surname>
                            <given-names>JR</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Anderson</surname>
                            <given-names>PL</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.</article-title>
                    <source>

                        <italic toggle="yes">N Engl J Med.</italic>
</source>
                    <year>2010</year>;<volume>363</volume>(<issue>27</issue>):<fpage>2587</fpage>&#x2013;<lpage>99</lpage>.
                    <pub-id pub-id-type="pmid">21091279</pub-id>
                    <pub-id pub-id-type="doi">10.1056/NEJMoa1011205</pub-id>
                    <pub-id pub-id-type="pmcid">3079639</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-7">
                <label>7</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Haberer</surname>
                            <given-names>JE</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Bangsberg</surname>
                            <given-names>DR</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Baeten</surname>
                            <given-names>JM</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm.</article-title>
                    <source>

                        <italic toggle="yes">AIDS.</italic>
</source>
                    <year>2015</year>;<volume>29</volume>(<issue>11</issue>):<fpage>1277</fpage>&#x2013;<lpage>85</lpage>.
                    <pub-id pub-id-type="pmid">26103095</pub-id>
                    <pub-id pub-id-type="doi">10.1097/QAD.0000000000000647</pub-id>
                    <pub-id pub-id-type="pmcid">4480436</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-8">
                <label>8</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Martin</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Vanichseni</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Suntharasamai</surname>
                            <given-names>P</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugs.</article-title>
                    <source>

                        <italic toggle="yes">AIDS.</italic>
</source>
                    <year>2015</year>;<volume>29</volume>(<issue>7</issue>):<fpage>819</fpage>&#x2013;<lpage>24</lpage>.
                    <pub-id pub-id-type="pmid">25985403</pub-id>
                    <pub-id pub-id-type="doi">10.1097/QAD.0000000000000613</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-9">
                <label>9</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>McCormack</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Dunn</surname>
                            <given-names>DT</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Desai</surname>
                            <given-names>M</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.</article-title>
                    <source>

                        <italic toggle="yes">Lancet.</italic>
</source>
                    <year>2016</year>;<volume>387</volume>(<issue>10013</issue>):<fpage>53</fpage>&#x2013;<lpage>60</lpage>.
                    <pub-id pub-id-type="pmid">26364263</pub-id>
                    <pub-id pub-id-type="doi">10.1016/S0140-6736(15)00056-2</pub-id>
                    <pub-id pub-id-type="pmcid">4700047</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-10">
                <label>10</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Ndase</surname>
                            <given-names>P</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Celum</surname>
                            <given-names>C</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Campbell</surname>
                            <given-names>J</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Successful discontinuation of the placebo arm and provision of an effective HIV prevention product after a positive interim efficacy result: the partners PrEP study experience.</article-title>
                    <source>

                        <italic toggle="yes">J Acquir Immune Defic Syndr.</italic>
</source>
                    <year>2014</year>;<volume>66</volume>(<issue>2</issue>):<fpage>206</fpage>&#x2013;<lpage>12</lpage>.
                    <pub-id pub-id-type="pmid">24828268</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-11">
                <label>11</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Thigpen</surname>
                            <given-names>MC</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Kebaabetswe</surname>
                            <given-names>PM</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Paxton</surname>
                            <given-names>LA</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.</article-title>
                    <source>

                        <italic toggle="yes">N Engl J Med.</italic>
</source>
                    <year>2012</year>;<volume>367</volume>(<issue>5</issue>):<fpage>423</fpage>&#x2013;<lpage>34</lpage>.
                    <pub-id pub-id-type="pmid">22784038</pub-id>
                    <pub-id pub-id-type="doi">10.1056/NEJMoa1110711</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-12">
                <label>12</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Ukpong</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Peterson</surname>
                            <given-names>K</given-names>
                        </name>
</person-group>:
                    <article-title>Oral tenofovir controversy II: Voices from the field. A series of reports of the oral Tenofovir trials with perspectives of community voices from Cambodia, Cameroon, Nigeria, Thailand and Malawi. New HIV Vaccine and Microbicides Advocacy Society (NHVMAS)</article-title>. Lagos, Nigeria.<year>2009</year>.
                    <ext-link ext-link-type="uri" xlink:href="https://www.academia.edu/6354983/Oral_Tenofovir_Controversy_II_-_Voices_from_the_Field_With_Morenike_Ukpong_">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref-13">
                <label>13</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Haire</surname>
                            <given-names>BG</given-names>
                        </name>
</person-group>:
                    <article-title>Because we can: clashes of perspective over researcher obligation in the failed PrEP trials.</article-title>
                    <source>

                        <italic toggle="yes">Dev World Bioeth.</italic>
</source>
                    <year>2011</year>;<volume>11</volume>(<issue>2</issue>):<fpage>63</fpage>&#x2013;<lpage>74</lpage>.
                    <pub-id pub-id-type="pmid">21266000</pub-id>
                    <pub-id pub-id-type="doi">10.1111/j.1471-8847.2010.00292.x</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-14">
                <label>14</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Peterson</surname>
                            <given-names>K</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Folayan</surname>
                            <given-names>MO</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Chigwedere</surname>
                            <given-names>E</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Saying 'No' to PrEP research in Malawi: what constitutes 'failure' in offshored HIV prevention research?</article-title>
                    <source>

                        <italic toggle="yes">Anthropol Med.</italic>
</source>
                    <year>2015</year>;<volume>22</volume>(<issue>3</issue>):<fpage>278</fpage>&#x2013;<lpage>94</lpage>.
                    <pub-id pub-id-type="pmid">26422196</pub-id>
                    <pub-id pub-id-type="doi">10.1080/13648470.2015.1081377</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-15">
                <label>15</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Kaplan</surname>
                            <given-names>K</given-names>
                        </name>
</person-group>:
                    <article-title>The Thailand Story</article-title>. In
                    <italic toggle="yes">Oral Tenofovir Controversy II</italic>. edited by Morenike Ukpong and Kris Peterson. Lagos: NVHMAS.<year>2009</year>.
                    <ext-link ext-link-type="uri" xlink:href="http://www.nhvmas-ng.org/publication/TDF2.pdf">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref-16">
                <label>16</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Peterson</surname>
                            <given-names>K</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Folayan</surname>
                            <given-names>MO</given-names>
                        </name>
</person-group>:
                    <article-title>Ethics and HIV prevention research: An analysis of the early tenofovir PrEP trial in Nigeria.</article-title>
                    <source>

                        <italic toggle="yes">Bioethics.</italic>
</source>
                    <year>2019</year>;<volume>33</volume>(<issue>1</issue>):<fpage>35</fpage>&#x2013;<lpage>42</lpage>.
                    <pub-id pub-id-type="pmid">30198594</pub-id>
                    <pub-id pub-id-type="doi">10.1111/bioe.12470</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-17">
                <label>17</label>
                <mixed-citation publication-type="journal">
                    <collab>UNAIDS</collab>:
                    <article-title>Good participatory practice: guidelines for biomedical HIV prevention trials</article-title>. Geneva: UNAIDS.<year>2011</year>.
                    <ext-link ext-link-type="uri" xlink:href="https://www.avac.org/resource/good-participatory-practice-guidelines-biomedical-hiv-prevention-trials-second-edition">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref-18">
                <label>18</label>
                <mixed-citation publication-type="journal">
                    <collab>UNAIDS, </collab>
                    <collab>WHO</collab>:
                    <article-title>Ethical considerations in biomedical HIV prevention trials [additional guidance point added in 2012]</article-title>.<year>2012</year>.
                    <ext-link ext-link-type="uri" xlink:href="http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2012/jc1399_ethical_considerations_en.pdf">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref-19">
                <label>19</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Heffron</surname>
                            <given-names>R</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ngure</surname>
                            <given-names>K</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Odoyo</surname>
                            <given-names>J</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East Africa [version 1; peer review: 2 approved].</article-title>
                    <source>

                        <italic toggle="yes">Gates Open Res.</italic>
</source>
                    <year>2017</year>;<volume>1</volume>:<fpage>3</fpage>.
                    <pub-id pub-id-type="pmid">29355231</pub-id>
                    <pub-id pub-id-type="doi">10.12688/gatesopenres.12752.1</pub-id>
                    <pub-id pub-id-type="pmcid">5757790</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-20">
                <label>20</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Baeten</surname>
                            <given-names>JM</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Heffron</surname>
                            <given-names>R</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Kidoguchi</surname>
                            <given-names>L</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Integrated delivery of antiretroviral treatment and pre-exposure prophylaxis to HIV-1-serodiscordant couples: a prospective implementation study in Kenya and Uganda.</article-title>
                    <source>

                        <italic toggle="yes">PLoS Med.</italic>
</source>
                    <year>2016</year>;<volume>13</volume>(<issue>8</issue>):<fpage>e1002099</fpage>.
                    <pub-id pub-id-type="pmid">27552090</pub-id>
                    <pub-id pub-id-type="doi">10.1371/journal.pmed.1002099</pub-id>
                    <pub-id pub-id-type="pmcid">4995047</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-21">
                <label>21</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Haberer</surname>
                            <given-names>JE</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Kidoguchi</surname>
                            <given-names>L</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Heffron</surname>
                            <given-names>R</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.</article-title>
                    <source>

                        <italic toggle="yes">J Int AIDS Soc.</italic>
</source>
                    <year>2017</year>;<volume>20</volume>(<issue>1</issue>):<fpage>21842</fpage>.
                    <pub-id pub-id-type="pmid">28741331</pub-id>
                    <pub-id pub-id-type="doi">10.7448/IAS.20.1.21842</pub-id>
                    <pub-id pub-id-type="pmcid">5577705</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-22">
                <label>22</label>
                <mixed-citation publication-type="journal">
                    <collab>AVAC</collab>:
                    <article-title>National Policies and Guidelines for PrEP</article-title>.
                    <ext-link ext-link-type="uri" xlink:href="https://www.prepwatch.org/prep-resources/national-policies-guidelines/">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref-23">
                <label>23</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Idoko</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Folayan</surname>
                            <given-names>MO</given-names>
                        </name>
</person-group>:
                    <article-title>The use of antiretroviral therapy for the prevention of new HIV infection in populations at high risk for HIV sero-conversion in Nigeria.</article-title>
                    <source>

                        <italic toggle="yes">Afr J Reprod Health.</italic>
</source>
                    <year>2014</year>;<volume>18</volume>(<issue>3 Spec No</issue>):<fpage>127</fpage>&#x2013;<lpage>34</lpage>.
                    <pub-id pub-id-type="pmid">26050385</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-24">
                <label>24</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Mitchell</surname>
                            <given-names>KM</given-names>
                        </name>

                        <name name-style="western">
                            <surname>L&#x00e9;pine</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Terris-Prestholt</surname>
                            <given-names>F</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Modelling the impact and cost-effectiveness of combination prevention amongst HIV serodiscordant couples in Nigeria.</article-title>
                    <source>

                        <italic toggle="yes">AIDS.</italic>
</source>
                    <year>2015</year>;<volume>29</volume>(<issue>15</issue>):<fpage>2035</fpage>&#x2013;<lpage>44</lpage>.
                    <pub-id pub-id-type="pmid">26355574</pub-id>
                    <pub-id pub-id-type="doi">10.1097/QAD.0000000000000798</pub-id>
                    <pub-id pub-id-type="pmcid">4568890</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-25">
                <label>25</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Idoko</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Folayan</surname>
                            <given-names>MO</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Dadem</surname>
                            <given-names>NY</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>&#x201c;Why should I take drugs for your infection?&#x201d;: outcomes of formative research on the use of HIV pre-exposure prophylaxis in Nigeria.</article-title>
                    <source>

                        <italic toggle="yes">BMC Public Health.</italic>
</source>
                    <year>2015</year>;<volume>15</volume>(<issue>1</issue>):<fpage>349</fpage>.
                    <pub-id pub-id-type="pmid">25881087</pub-id>
                    <pub-id pub-id-type="doi">10.1186/s12889-015-1690-9</pub-id>
                    <pub-id pub-id-type="pmcid">4404045</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-26">
                <label>26</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Karuga</surname>
                            <given-names>RN</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Njenga</surname>
                            <given-names>SN</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Mulwa</surname>
                            <given-names>R</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>&#x201c;How I wish this thing was initiated 100 years ago!&#x201d; willingness to take daily oral pre-exposure prophylaxis among men who have sex with men in Kenya.</article-title>
                    <source>

                        <italic toggle="yes">PLoS One.</italic>
</source>
                    <year>2016</year>;<volume>11</volume>(<issue>4</issue>):<fpage>e0151716</fpage>.
                    <pub-id pub-id-type="pmid">27073896</pub-id>
                    <pub-id pub-id-type="doi">10.1371/journal.pone.0151716</pub-id>
                    <pub-id pub-id-type="pmcid">4830617</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-27">
                <label>27</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Eakle</surname>
                            <given-names>R</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Gomez</surname>
                            <given-names>GB</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Naicker</surname>
                            <given-names>N</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project.</article-title>
                    <source>

                        <italic toggle="yes">PLoS Med.</italic>
</source>
                    <year>2017</year>;<volume>14</volume>(<issue>11</issue>):<fpage>e1002444</fpage>.
                    <pub-id pub-id-type="pmid">29161256</pub-id>
                    <pub-id pub-id-type="doi">10.1371/journal.pmed.1002444</pub-id>
                    <pub-id pub-id-type="pmcid">5697804</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-28">
                <label>28</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Eakle</surname>
                            <given-names>R</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Mutanha</surname>
                            <given-names>N</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Mbogua</surname>
                            <given-names>J</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Designing PrEP and early HIV treatment interventions for implementation among female sex workers in South Africa: developing and learning from a formative research process.</article-title>
                    <source>

                        <italic toggle="yes">BMJ Open.</italic>
</source>
                    <year>2018</year>;<volume>8</volume>(<issue>6</issue>):<fpage>e019292</fpage>.
                    <pub-id pub-id-type="pmid">29903784</pub-id>
                    <pub-id pub-id-type="doi">10.1136/bmjopen-2017-019292</pub-id>
                    <pub-id pub-id-type="pmcid">6009452</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-29">
                <label>29</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Reza-Paul</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Lazarus</surname>
                            <given-names>L</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Doshi</surname>
                            <given-names>M</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Prioritizing Risk in Preparation for a Demonstration Project: A Mixed Methods Feasibility Study of Oral Pre-Exposure Prophylaxis (PREP) among Female Sex Workers in South India.</article-title>
                    <source>

                        <italic toggle="yes">PLoS One.</italic>
</source>
                    <year>2016</year>;<volume>11</volume>(<issue>11</issue>):<fpage>e0166889</fpage>.
                    <pub-id pub-id-type="pmid">27880833</pub-id>
                    <pub-id pub-id-type="doi">10.1371/journal.pone.0166889</pub-id>
                    <pub-id pub-id-type="pmcid">5120793</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-30">
                <label>30</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Msuya</surname>
                            <given-names>SE</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Mbizvo</surname>
                            <given-names>EM</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Hussain</surname>
                            <given-names>A</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Low male partner participation in antenatal HIV counselling and testing in northern Tanzania: implications for preventive programs.</article-title>
                    <source>

                        <italic toggle="yes">AIDS Care.</italic>
</source>
                    <year>2008</year>;<volume>20</volume>(<issue>6</issue>):<fpage>700</fpage>&#x2013;<lpage>9</lpage>.
                    <pub-id pub-id-type="pmid">18576172</pub-id>
                    <pub-id pub-id-type="doi">10.1080/09540120701687059</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-31">
                <label>31</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Bwambale</surname>
                            <given-names>FM</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ssali</surname>
                            <given-names>SN</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Byaruhanga</surname>
                            <given-names>S</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Voluntary HIV counselling and testing among men in rural western Uganda: implications for HIV prevention.</article-title>
                    <source>

                        <italic toggle="yes">BMC Public Health.</italic>
</source>
                    <year>2008</year>;<volume>8</volume>(<issue>1</issue>):<fpage>263</fpage>.
                    <pub-id pub-id-type="pmid">18664301</pub-id>
                    <pub-id pub-id-type="doi">10.1186/1471-2458-8-263</pub-id>
                    <pub-id pub-id-type="pmcid">2529297</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-32">
                <label>32</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Desgr&#x00e9;es-du-Lo&#x00fb;</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Orne-Gliemann</surname>
                            <given-names>J</given-names>
                        </name>
</person-group>:
                    <article-title>Couple-centred testing and counselling for HIV serodiscordant heterosexual couples in sub-Saharan Africa.</article-title>
                    <source>

                        <italic toggle="yes">Reprod Health Matters.</italic>
</source>
                    <year>2008</year>;<volume>16</volume>(<issue>32</issue>):<fpage>151</fpage>&#x2013;<lpage>61</lpage>.
                    <pub-id pub-id-type="pmid">19027631</pub-id>
                    <pub-id pub-id-type="doi">10.1016/S0968-8080(08)32407-0</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-33">
                <label>33</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Ngure</surname>
                            <given-names>K</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Heffron</surname>
                            <given-names>R</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Curran</surname>
                            <given-names>K</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>
                        <italic toggle="yes">I Knew I Would Be Safer</italic>. Experiences of Kenyan HIV Serodiscordant Couples Soon After Pre-Exposure Prophylaxis (PrEP) Initiation.</article-title>
                    <source>

                        <italic toggle="yes">AIDS Patient Care STDS.</italic>
</source>
                    <year>2016</year>;<volume>30</volume>(<issue>2</issue>):<fpage>78</fpage>&#x2013;<lpage>83</lpage>.
                    <pub-id pub-id-type="pmid">26836236</pub-id>
                    <pub-id pub-id-type="doi">10.1089/apc.2015.0259</pub-id>
                    <pub-id pub-id-type="pmcid">4753630</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-34">
                <label>34</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Simoni</surname>
                            <given-names>JM</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Nelson</surname>
                            <given-names>KM</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Franks</surname>
                            <given-names>JC</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Are peer interventions for HIV efficacious? A systematic review.</article-title>
                    <source>

                        <italic toggle="yes">AIDS Behav.</italic>
</source>
                    <year>2011</year>;<volume>15</volume>(<issue>8</issue>):<fpage>1589</fpage>&#x2013;<lpage>95</lpage>.
                    <pub-id pub-id-type="pmid">21598034</pub-id>
                    <pub-id pub-id-type="doi">10.1007/s10461-011-9963-5</pub-id>
                    <pub-id pub-id-type="pmcid">3607378</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-35">
                <label>35</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Lazarus</surname>
                            <given-names>L</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Reza-Paul</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Pasha</surname>
                            <given-names>A</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Exploring the role of community-based peer support in improving access to care and antiretroviral treatment for sex workers in Mysore, India.</article-title>
                    <source>

                        <italic toggle="yes">HIV Social Services.</italic>
</source>
                    <year>2012</year>;<volume>11</volume>:<fpage>152</fpage>&#x2013;<lpage>168</lpage>.
                    <pub-id pub-id-type="doi">10.1080/15381501.2012.678132</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-36">
                <label>36</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Chevrier</surname>
                            <given-names>C</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Khan</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Reza-Paul</surname>
                            <given-names>S</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>&#x2018;No one was there to care for us&#x2019;: Ashodaya Samithi's community-led care and support for people living with HIV in Mysore, India.</article-title>
                    <source>

                        <italic toggle="yes">Glob Public Health.</italic>
</source>
                    <year>2016</year>;<volume>11</volume>(<issue>4</issue>):<fpage>423</fpage>&#x2013;<lpage>36</lpage>.
                    <pub-id pub-id-type="pmid">26548553</pub-id>
                    <pub-id pub-id-type="doi">10.1080/17441692.2015.1091488</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-37">
                <label>37</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Enriquez</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Cheng</surname>
                            <given-names>AL</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Banderas</surname>
                            <given-names>J</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>A Peer-Led HIV Medication Adherence Intervention Targeting Adults Linked to Medical Care but without a Suppressed Viral Load.</article-title>
                    <source>

                        <italic toggle="yes">J Int Assoc Provid AIDS Care.</italic>
</source>
                    <year>2015</year>;<volume>14</volume>(<issue>5</issue>):<fpage>441</fpage>&#x2013;<lpage>8</lpage>.
                    <pub-id pub-id-type="pmid">25412724</pub-id>
                    <pub-id pub-id-type="doi">10.1177/2325957414558301</pub-id>
                    <pub-id pub-id-type="pmcid">5677528</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-38">
                <label>38</label>
                <mixed-citation publication-type="journal">
                    <article-title>WHO Implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection</article-title>. Module 2: Community educators and advocates. Geneva: World Health Organization;<year>2017</year>.
                    <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/iris/bitstream/10665/258514/1/WHO-HIV-2017.28-eng.pdf?ua=1">Reference Source</ext-link>
                </mixed-citation>
            </ref>
        </ref-list>
    </back>
    <sub-article article-type="reviewer-report" id="report27496">
        <front-stub>
            <article-id pub-id-type="doi">10.21956/gatesopenres.14158.r27496</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>MacQueen</surname>
                        <given-names>Kathleen M.</given-names>
                    </name>
                    <xref ref-type="aff" rid="r27496a1">1</xref>
                    <xref ref-type="aff" rid="r27496a2">2</xref>
                    <xref ref-type="aff" rid="r27496a3">3</xref>
                    <role>Referee</role>
                    <uri content-type="orcid">https://orcid.org/0000-0003-2436-4741</uri>
                </contrib>
                <aff id="r27496a1">
                    <label>1</label>Global Health Research, FHI 360, Durham, NC, USA</aff>
                <aff id="r27496a2">
                    <label>2</label>University of North Carolina Center for AIDS Research, Chapel Hill, NC, USA</aff>
                <aff id="r27496a3">
                    <label>3</label>Social Medicine Department, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>13</day>
                <month>8</month>
                <year>2019</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2019 MacQueen KM</copyright-statement>
                <copyright-year>2019</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport27496" related-article-type="peer-reviewed-article" xlink:href="10.12688/gatesopenres.13042.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve-with-reservations</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>
                <underline>Summary:</underline> 
                <list list-type="bullet">
                    <list-item>
                        <p>The open letter is a valuable description of the community engagement practices implemented in seven BMGF-funded PrEP demonstration projects in various sites in Kenya, Uganda, Nigeria, Benin, Senegal, South Africa, and India. The projects focused primarily on serodiscordant couples and female sex workers and were variously implemented by in-country and expat research centres, as well as community-based and advocacy organizations. Direct governmental participation in the projects is unclear and it would be helpful to have that clarified.</p>
                    </list-item>
                    <list-item>
                        <p>The projects varied with regard to the community engagement strategies used. Using data from an open-ended questionnaire completed by members of each project and follow-up phone interviews with some projects, case studies were developed describing the role of community at various stages of the projects. With input from the projects, the case studies were then assessed for commonalities and lessons learned.</p>
                    </list-item>
                    <list-item>
                        <p>The rationale for the open letter is clearly articulated in the Background section. The authors cite the controversial history of early PrEP trials that led to more proactive community engagement. They note the importance of sustaining community participation in the context of PrEP demonstration projects, especially given the diversity of settings and at-risk populations. The letter seeks to add to the documentation of practice and lessons learned across the diverse settings, providing a range of views and experiences on the topic.</p>
                    </list-item>
                </list> &#x00a0;</p>
            <p> 
                <underline>Major points to address:</underline> 
                <list list-type="bullet">
                    <list-item>
                        <p>To more adequately represent the diversity of opinion on community engagement (CE) in the projects, it would be helpful if the authors included a statement describing how each project conceptualized the role of CE in their project and how success was defined by each project. This information is woven into the case studies (for the most part) but the reader would benefit from articulation of role/desired outcomes in the opening paragraph for each case study.</p>
                    </list-item>
                    <list-item>
                        <p>The richness of the case studies is quite variable, and it is difficult to determine if this is due to the complexity or comprehensiveness of the CE work across projects/sites or due to limitations in the data collected for each case study. Clarification on this is needed.</p>
                    </list-item>
                    <list-item>
                        <p>The descriptions of post-project outcomes related to sustainability of PrEP access, dissemination, PrEP advocacy, and on-going work related to community engagement in these processes is very helpful. Explicit commentary on barriers and challenges would also be helpful, especially if any of the projects have reflected on what they would do differently based on their experience. Some of this alluded to but not explicitly addressed, making it difficult for the reader to parse across the case studies.</p>
                    </list-item>
                    <list-item>
                        <p>P. 3, under Findings: The opening paragraph lists populations targeted but omits MSM and young women, who are described as participants in some case studies.</p>
                    </list-item>
                    <list-item>
                        <p>P. 4, Table 1: The Implementer column is ambiguous as to whether the organizations listed were responsible for the PrEP demonstration project, the community engagement work, or both. Clearer understanding of the relative independence of the CE work for each project would help the reader and potentially add insight to the lessons learned.</p>
                    </list-item>
                    <list-item>
                        <p>P. 4, Partners Project: From the description it appears that the CHWs had built considerable trust with the community prior to their engagement with the project. The project was then able to leverage this existing trust &#x2014; an important nuance. A key question then becomes, how did implementers build trust with the CHWs? CHWs risked undermining the community trust they previously established, if they did not negotiate trust-building with the implementers. This is important context to understand for lessons learned.</p>
                    </list-item>
                    <list-item>
                        <p>P. 6, second full paragraph: The last sentence states that CWs in Benin &#x201c;simultaneously addressed concerns in the community&#x201d; while working one-on-one with project participants. What strategies did the CWs use to address community concerns? What types of concerns emerged? How were they addressed?</p>
                    </list-item>
                    <list-item>
                        <p>Pp. 6-7, IPCP project: It is unclear whether or how the project CAB and site level community advisory committees interacted or had overlapping membership; this should be clarified. Also, to what extent were these two types of advisory groups engaged in addressing the LVCT crisis when the young men stormed the offices? Was representation at the site level expanded to include young men? Or was expanded stakeholder engagement distinct from the established advisory mechanisms?</p>
                    </list-item>
                    <list-item>
                        <p>P. 7, TAPS project: It is unclear whether the mobile clinic service for sex workers was established specifically to facilitate project recruitment, or to address unmet needs for sex workers generally. I.e., was the mobile clinic exploiting unmet needs for recruitment purposes or was the project leveraged to address those needs with an eye toward sustainability beyond the project?</p>
                    </list-item>
                    <list-item>
                        <p>P. 8, Ashodaya Samithi project: The authors state that sex work community leaders were the first participants who then &#x201c;went on to recruit and mobilize participants through their peer networks.&#x201d; To what extent was this recruitment/mobilization role fostered by the project staff? Were the leaders an integral part of the sex work collective implementing the project? If not, were they paid for taking on the recruitment/mobilization role? How was their role related to the community mobilizers, who are also described as having major roles in recruitment and follow-up?</p>
                    </list-item>
                    <list-item>
                        <p>Discussion section: It would be helpful to include an explicit discussion of gender power dynamics and how these were handled in the various projects. Some sites broadened outreach to stakeholders with power/authority over young women (YW) and FSWs in particular, to gain the support of such stakeholders for participation of YW/FSW in the PrEP programmes. Gender integration is often conceptualized as a continuum from exploitation to accommodation to transformation of inequalities/inequities. To what extent were projects consciously addressing this continuum in their choice of strategies? What lessons emerged with regard to gender integration in the various PrEP programmes?</p>
                    </list-item>
                </list>
            </p>
            <p>Does the article adequately reference differing views and opinions?</p>
            <p>Partly</p>
            <p>Are all factual statements correct, and are statements and arguments made adequately supported by citations?</p>
            <p>Yes</p>
            <p>Is the Open Letter written in accessible language?</p>
            <p>Yes</p>
            <p>Where applicable, are recommendations and next steps explained clearly for others to follow?</p>
            <p>Partly</p>
            <p>Is the rationale for the Open Letter provided in sufficient detail?</p>
            <p>Yes</p>
            <p>Reviewer Expertise:</p>
            <p>Social, behavioral and ethical dimensions of biomedical HIV prevention research; community engagement in research; Good Participatory Practice in research; community-based participatory research; qualitative research; mixed-methods research</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.</p>
        </body>
        <sub-article article-type="response" id="comment3250-27496">
            <front-stub>
                <contrib-group>
                    <contrib contrib-type="author">
                        <name>
                            <surname>Lazarus</surname>
                            <given-names>Lisa</given-names>
                        </name>
                        <aff/>
                    </contrib>
                </contrib-group>
                <author-notes>
                    <fn fn-type="conflict">
                        <p>
                            <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                    </fn>
                </author-notes>
                <pub-date pub-type="epub">
                    <day>4</day>
                    <month>12</month>
                    <year>2019</year>
                </pub-date>
            </front-stub>
            <body>
                <p>
                    <list list-type="bullet">
                        <list-item>
                            <p>The open letter is a valuable description of the community engagement practices implemented in seven BMGF-funded PrEP demonstration projects in various sites in Kenya, Uganda, Nigeria, Benin, Senegal, South Africa, and India. The projects focused primarily on serodiscordant couples and female sex workers and were variously implemented by in-country and expat research centres, as well as community-based and advocacy organizations. Direct governmental participation in the projects is unclear and it would be helpful to have that clarified.</p>
                        </list-item>
                        <list-item>
                            <p>The projects varied with regard to the community engagement strategies used. Using data from an open-ended questionnaire completed by members of each project and follow-up phone interviews with some projects, case studies were developed describing the role of community at various stages of the projects. With input from the projects, the case studies were then assessed for commonalities and lessons learned.</p>
                        </list-item>
                        <list-item>
                            <p>The rationale for the open letter is clearly articulated in the Background section. The authors cite the controversial history of early PrEP trials that led to more proactive community engagement. They note the importance of sustaining community participation in the context of PrEP demonstration projects, especially given the diversity of settings and at-risk populations. The letter seeks to add to the documentation of practice and lessons learned across the diverse settings, providing a range of views and experiences on the topic.</p>
                        </list-item>
                    </list> 
                    <italic>- We thank the reviewer for their feedback on our open letter and have provided detailed responses to the specific queries below.</italic>
                </p>
                <p>
                    <underline>Major points to address:</underline> 
                    <list list-type="bullet">
                        <list-item>
                            <p>To more adequately represent the diversity of opinion on community engagement (CE) in the projects, it would be helpful if the authors included a statement describing how each project conceptualized the role of CE in their project and how success was defined by each project. This information is woven into the case studies (for the most part) but the reader would benefit from articulation of role/desired outcomes in the opening paragraph for each case study.</p>
                        </list-item>
                    </list> 
                    <italic>-Thank you for raising this important point. We have included statements on how each project conceptualized community engagement at the start of each case study, following the overall objective, and also worked to describe project success towards the end of each case study.</italic>
                </p>
                <p>&#x00a0; 
                    <list list-type="bullet">
                        <list-item>
                            <p>The richness of the case studies is quite variable, and it is difficult to determine if this is due to the complexity or comprehensiveness of the CE work across projects/sites or due to limitations in the data collected for each case study. Clarification on this is needed.</p>
                        </list-item>
                    </list> 
                    <italic>-Thank you for this query. The variability is due to the different levels of engagement, based on the existing roles of communities in each environment. We have attempted to address this in the Discussion with the following statement: &#x201c;While the case studies presented here are limited in scope, they provide important insight into the ways that communities are engaged in PrEP demonstration projects globally. As each site developed contextually-specific approaches to rolling out their demonstration projects, comparison of the case studies could not be done. Yet, context-specific designs were important for the community engagement programs to be successful. Therefore, these studies provide important insights on ways to engage communities in biomedically-focused research and programs.&#x201d;</italic> 
                    <list list-type="bullet">
                        <list-item>
                            <p>The descriptions of post-project outcomes related to sustainability of PrEP access, dissemination, PrEP advocacy, and on-going work related to community engagement in these processes is very helpful. Explicit commentary on barriers and challenges would also be helpful, especially if any of the projects have reflected on what they would do differently based on their experience. Some of this alluded to but not explicitly addressed, making it difficult for the reader to parse across the case studies.</p>
                        </list-item>
                    </list> 
                    <italic>-Thank you for raising this important point. We have added details about challenges faced and whether there are some steps that projects would have done differently to the case studies.&#x00a0;</italic> 
                    <list list-type="bullet">
                        <list-item>
                            <p>P. 3, under Findings: The opening paragraph lists populations targeted but omits MSM and young women, who are described as participants in some case studies.</p>
                        </list-item>
                    </list> 
                    <italic>-Thank you for catching this. It was been corrected.</italic>
                </p>
                <p>&#x00a0; 
                    <list list-type="bullet">
                        <list-item>
                            <p>P. 4, Table 1: The Implementer column is ambiguous as to whether the organizations listed were responsible for the PrEP demonstration project, the community engagement work, or both. Clearer understanding of the relative independence of the CE work for each project would help the reader and potentially add insight to the lessons learned.</p>
                        </list-item>
                    </list> 
                    <italic>- All implementers were involved in leading the project. Where appropriate, community organizations involved in all aspects of study implementation have also been included in the Table. Details of community partners involved in some areas of community engagement are included in the case studies.</italic> 
                    <list list-type="bullet">
                        <list-item>
                            <p>P. 4, Partners Project: From the description it appears that the CHWs had built considerable trust with the community prior to their engagement with the project. The project was then able to leverage this existing trust &#x2014; an important nuance. A key question then becomes, how did implementers build trust with the CHWs? CHWs risked undermining the community trust they previously established, if they did not negotiate trust-building with the implementers. This is important context to understand for lessons learned.</p>
                        </list-item>
                    </list> 
                    <italic>-We have clarified that the Partners PrEP demonstration project builds on the previous PrEP trial. CHWs had been involved in the previous trial, therefore the demonstration project builds from this previous work and previously developed relationships.</italic> 
                    <list list-type="bullet">
                        <list-item>
                            <p>P. 6, second full paragraph: The last sentence states that CWs in Benin &#x201c;simultaneously addressed concerns in the community&#x201d; while working one-on-one with project participants. What strategies did the CWs use to address community concerns? What types of concerns emerged? How were they addressed?</p>
                        </list-item>
                    </list> 
                    <italic>- Thank you for this question. We have revised the Benin case study to provide more details. Specifically, we have clarified that catchment areas were divided in a way that allowed for CWs, who were from NGOS working with sex workers, to frequently meet and support FSWs in the field. CWs worked to promote adherence, addressed concerns about side effects, and located women lost to follow up during their field visits.</italic> 
                    <list list-type="bullet">
                        <list-item>
                            <p>Pp. 6-7, IPCP project: It is unclear whether or how the project CAB and site level community advisory committees interacted or had overlapping membership; this should be clarified. Also, to what extent were these two types of advisory groups engaged in addressing the LVCT crisis when the young men stormed the offices? Was representation at the site level expanded to include young men? Or was expanded stakeholder engagement distinct from the established advisory mechanisms?</p>
                        </list-item>
                    </list> 
                    <italic>-We have clarified the different memberships and roles of the national-level CAB, as compared to the site and population specific community advisory committees in the IPCP case study. We have also specified that both the CAB and CAC were involved in addressing the crisis, along with engaging other important stakeholders.</italic>
                </p>
                <p>&#x00a0; 
                    <list list-type="bullet">
                        <list-item>
                            <p>P. 7, TAPS project: It is unclear whether the mobile clinic service for sex workers was established specifically to facilitate project recruitment, or to address unmet needs for sex workers generally. I.e., was the mobile clinic exploiting unmet needs for recruitment purposes or was the project leveraged to address those needs with an eye toward sustainability beyond the project?</p>
                        </list-item>
                    </list> 
                    <italic>-Thank you for this query. We have clarified the above with the following statement: &#x201c;A mobile clinic service was established to access and create demand for sex workers who were based farther away from the clinics. The mobile clinic was leveraged from the SWP clinic to recruit FSWs who were not able to access the clinic either because of distance or due to the clinic operating hours. These processes facilitated recruitment.&#x201d;</italic> 
                    <list list-type="bullet">
                        <list-item>
                            <p>P. 8, Ashodaya Samithi project: The authors state that sex work community leaders were the first participants who then &#x201c;went on to recruit and mobilize participants through their peer networks.&#x201d; To what extent was this recruitment/mobilization role fostered by the project staff? Were the leaders an integral part of the sex work collective implementing the project? If not, were they paid for taking on the recruitment/mobilization role? How was their role related to the community mobilizers, who are also described as having major roles in recruitment and follow-up?</p>
                        </list-item>
                    </list> 
                    <italic>-Thank you for this question. As Ashodaya is a sex work-led organizations, community leaders took on central roles in all aspects of the project from design to implementation. We have clarified that: &#x201c;Sex work community leaders and community mobilizers, who are longstanding members of the organization and were involved in the discussions surrounding initiating and planning the demonstration project, volunteered to be the first participants enrolled in the study, which built trust in the project.&#x201d;</italic>
                </p>
                <p>&#x00a0; 
                    <list list-type="bullet">
                        <list-item>
                            <p>Discussion section: It would be helpful to include an explicit discussion of gender power dynamics and how these were handled in the various projects. Some sites broadened outreach to stakeholders with power/authority over young women (YW) and FSWs in particular, to gain the support of such stakeholders for participation of YW/FSW in the PrEP programmes. Gender integration is often conceptualized as a continuum from exploitation to accommodation to transformation of inequalities/inequities. To what extent were projects consciously addressing this continuum in their choice of strategies? What lessons emerged with regard to gender integration in the various PrEP programmes?</p>
                        </list-item>
                    </list> 
                    <italic>-While we agree that an analysis of gender power dynamics would make an important contribution to this work, it is beyond the scope of this open letter. The independent project sites will explore this in their own site-specific papers.</italic>
                </p>
            </body>
        </sub-article>
    </sub-article>
    <sub-article article-type="reviewer-report" id="report27498">
        <front-stub>
            <article-id pub-id-type="doi">10.21956/gatesopenres.14158.r27498</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Tan</surname>
                        <given-names>Darrell H S</given-names>
                    </name>
                    <xref ref-type="aff" rid="r27498a1">1</xref>
                    <role>Referee</role>
                    <uri content-type="orcid">https://orcid.org/0000-0002-3069-2875</uri>
                </contrib>
                <contrib contrib-type="author">
                    <name>
                        <surname>Truong</surname>
                        <given-names>Robinson</given-names>
                    </name>
                    <xref ref-type="aff" rid="r27498a2">2</xref>
                    <role>Co-referee</role>
                </contrib>
                <aff id="r27498a1">
                    <label>1</label>Division of Infectious Diseases, St. Michael's Hospital, Toronto, ON, Canada</aff>
                <aff id="r27498a2">
                    <label>2</label>St. Michael's Hospital, Toronto, Ontario, Canada</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>30</day>
                <month>7</month>
                <year>2019</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2019 Tan DHS and Truong R</copyright-statement>
                <copyright-year>2019</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport27498" related-article-type="peer-reviewed-article" xlink:href="10.12688/gatesopenres.13042.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve-with-reservations</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>This open letter is a narrative review describing community engagement activities undertaken within seven PrEP demonstration projects funded by the Gates foundation. The authors rightly emphasize the importance of inclusive community engagement in such studies by citing the lack of such work in the early tenofovir trials. Overall the article provides a concise summary and includes descriptions that may be of interest to researchers planning future HIV prevention or global health intervention studies.&#x00a0;A few suggestions follow.</p>
            <p> </p>
            <p> Major comments: 
                <list list-type="order">
                    <list-item>
                        <p>It would be helpful for the abstract to mention some of the key actual lessons learned, rather than only stating that lessons learned are included in the body of the article.</p>
                    </list-item>
                    <list-item>
                        <p>It would be helpful if each of the case studies were structured in a similar way and contained the same key elements. At present, most open with a paragraph outlining who the study implementers were, and then describe who the key actors were for the community engagement, specific activities undertaken by those community-based actors, challenges encountered, and commentary about the current status of PrEP funding in the local setting. In particular, only a minority of the case studies clearly describe challenges faced by the study teams in working with community, which may be of particular interest to those hoping to learn from these experiences. Also, statements about the availability and cost of PrEP in some of the examples could be clearer (e.g. India, Partners does not comment on Uganda). Finally, it would be appropriate to add a clear brief statement about the overarching goal or primary objective for each project; this was often but not always done.</p>
                    </list-item>
                    <list-item>
                        <p>To make the case studies as useful as possible for readers interested in implementing similar community engagement work, it would be helpful for the case studies to be as specific as possible, perhaps including operational details such as exactly how the key actors (CAB members, community workers, peer educators etc.) were selected, how many were engaged and why, and specific activities undertaken by these individuals. In some cases, relevant details are lacking, making the information potentially less useful to readers. For instance, the Partners PrEP description contains a series of somewhat vague statements about a variety of community actors doing various general types of activities, without really specifying who was responsible for taking on which specific actions; e.g. there is mention of lead members of community organizations, CAGs, CHWs, and serodiscordant couple groups, but the rationale for and differences between these agents was not clear, and there is separate mention in different places of having &#x201c;worked with stakeholders to dispel myths, rumours etc&#x201d;, being &#x201c;agents who interacted with the local communities&#x201d;, &#x201c;regular engagements with various stakeholders&#x201d; etc.&#x00a0; Similarly, in the Nigerian case study, many activities are described in the passive voice, making it again less clear which actors undertook which activities (&#x201c;letters were sent&#x2026;&#x201d;, &#x201c;monthly meetings were held&#x2026;&#x201d; etc); presumably many of these were activities organized by the investigators to support the community partners but this could be clearer.</p>
                    </list-item>
                    <list-item>
                        <p>The authors could consider including a box or Table that lists common key elements of successful community engagement in these diverse projects, with the goal of helping readers see at a glance what specific advantages there may be to such work, and how it might be approached.&#x00a0; &#x00a0;</p>
                        <p> &#x00a0;&#x00a0; &#x00a0; &#x00a0; &#x00a0; &#x00a0; &#x00a0; &#x00a0;</p>
                    </list-item>
                </list> Minor comments: 
                <list list-type="order">
                    <list-item>
                        <p>The introductory paragraph could specify the particular tenofovir prodrug as TDF (versus TAF).</p>
                    </list-item>
                    <list-item>
                        <p>In the background, it may be appropriate to briefly mention the ethical violations that are alluded to (and cited) in the second paragraph.</p>
                    </list-item>
                    <list-item>
                        <p>At the end of the background, it might be helpful to state that the purpose of the paper is not only to articulate the community engagement practices implemented in the projects but also to explicitly inform future work with appropriate community engagement/advise other investigators on how to do such work.</p>
                    </list-item>
                    <list-item>
                        <p>The Partners PrEP description contains a somewhat confusing statement about how community entry was initiated by seeking government approval; what exactly was meant by this? &#x00a0;</p>
                    </list-item>
                    <list-item>
                        <p>Later in the same paragraph the authors say that &#x201c;site projects instituted CAGs&#x201d;; is this a typo that should have read &#x201c;project sites&#x201d;?</p>
                    </list-item>
                    <list-item>
                        <p>When describing lessons learned, the Discussion mentions that special attention should be paid to handling &#x201c;crises&#x201d; in serodiscordant couples, but this concept was not really explained in the case studies themselves (except when mentioning that some couples faced &#x201c;challenges&#x201d; in Partners PrEP).</p>
                    </list-item>
                </list>
            </p>
            <p>Does the article adequately reference differing views and opinions?</p>
            <p>Yes</p>
            <p>Are all factual statements correct, and are statements and arguments made adequately supported by citations?</p>
            <p>Yes</p>
            <p>Is the Open Letter written in accessible language?</p>
            <p>Yes</p>
            <p>Where applicable, are recommendations and next steps explained clearly for others to follow?</p>
            <p>Partly</p>
            <p>Is the rationale for the Open Letter provided in sufficient detail?</p>
            <p>Yes</p>
            <p>Reviewer Expertise:</p>
            <p>Infectious diseases</p>
            <p>We confirm that we have read this submission and believe that we have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however we have significant reservations, as outlined above.</p>
        </body>
        <sub-article article-type="response" id="comment3249-27498">
            <front-stub>
                <contrib-group>
                    <contrib contrib-type="author">
                        <name>
                            <surname>Lazarus</surname>
                            <given-names>Lisa</given-names>
                        </name>
                        <aff/>
                    </contrib>
                </contrib-group>
                <author-notes>
                    <fn fn-type="conflict">
                        <p>
                            <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                    </fn>
                </author-notes>
                <pub-date pub-type="epub">
                    <day>4</day>
                    <month>12</month>
                    <year>2019</year>
                </pub-date>
            </front-stub>
            <body>
                <p>This open letter is a narrative review describing community engagement activities undertaken within seven PrEP demonstration projects funded by the Gates foundation. The authors rightly emphasize the importance of inclusive community engagement in such studies by citing the lack of such work in the early tenofovir trials. Overall the article provides a concise summary and includes descriptions that may be of interest to researchers planning future HIV prevention or global health intervention studies.&#x00a0;A few suggestions follow.</p>
                <p>
                    <italic>We thank the reviewer for their feedback on our open letter and have provided detail responses to the specific queries below.</italic>
                </p>
                <p>Major comments:</p>
                <p>1.&#x00a0;It would be helpful for the abstract to mention some of the key actual lessons learned, rather than only stating that lessons learned are included in the body of the article.</p>
                <p>
                    <italic>-We have added lessons learned to the abstract.</italic>
                </p>
                <p>2. It would be helpful if each of the case studies were structured in a similar way and contained the same key elements. At present, most open with a paragraph outlining who the study implementers were, and then describe who the key actors were for the community engagement, specific activities undertaken by those community-based actors, challenges encountered, and commentary about the current status of PrEP funding in the local setting. In particular, only a minority of the case studies clearly describe challenges faced by the study teams in working with community, which may be of particular interest to those hoping to learn from these experiences. Also, statements about the availability and cost of PrEP in some of the examples could be clearer (e.g. India, Partners does not comment on Uganda). Finally, it would be appropriate to add a clear brief statement about the overarching goal or primary objective for each project; this was often but not always done.</p>
                <p>
                    <italic>-Thank you for this important comment. We have worked to revise the case studies to ensure that they all present the overall purpose of the project, key actors involved, activities undertaken for community engagement, challenges faced, and project outcomes as they relate to the current status of PrEP in each site. In particular, we have included challenges faced and addressed in the different projects. We have also clarified current PrEP status in India and Uganda.</italic>
                </p>
                <p>3. To make the case studies as useful as possible for readers interested in implementing similar community engagement work, it would be helpful for the case studies to be as specific as possible, perhaps including operational details such as exactly how the key actors (CAB members, community workers, peer educators etc.) were selected, how many were engaged and why, and specific activities undertaken by these individuals. In some cases, relevant details are lacking, making the information potentially less useful to readers. For instance, the Partners PrEP description contains a series of somewhat vague statements about a variety of community actors doing various general types of activities, without really specifying who was responsible for taking on which specific actions; e.g. there is mention of lead members of community organizations, CAGs, CHWs, and serodiscordant couple groups, but the rationale for and differences between these agents was not clear, and there is separate mention in different places of having &#x201c;worked with stakeholders to dispel myths, rumours etc&#x201d;, being &#x201c;agents who interacted with the local communities&#x201d;, &#x201c;regular engagements with various stakeholders&#x201d; etc.&#x00a0; Similarly, in the Nigerian case study, many activities are described in the passive voice, making it again less clear which actors undertook which activities (&#x201c;letters were sent&#x2026;&#x201d;, &#x201c;monthly meetings were held&#x2026;&#x201d; etc); presumably many of these were activities organized by the investigators to support the community partners but this could be clearer.</p>
                <p>
                    <italic>-We have added more details to each of the case studies, including how key actors were selected for different community engagement strategies and the number of people engaged in different activities. This includes revisions to both the Partners and Nigerian case studies, in order to provide further clarity to the different activities.</italic>
                </p>
                <p>4.&#x00a0;The authors could consider including a box or Table that lists common key elements of successful community engagement in these diverse projects, with the goal of helping readers see at a glance what specific advantages there may be to such work, and how it might be approached.&#x00a0; &#x00a0;</p>
                <p>
                    <italic>-Thank you for this suggestion. We have added Box 1 in the Discussion section that highlights the common key elements of community engagement.&#x00a0;&#x00a0; </italic>&#x00a0; &#x00a0; &#x00a0; &#x00a0; &#x00a0; &#x00a0;</p>
                <p>Minor comments:</p>
                <p>1.&#x00a0;The introductory paragraph could specify the particular tenofovir prodrug as TDF (versus TAF).</p>
                <p>
                    <italic>-This has been added.</italic>
                </p>
                <p>2. In the background, it may be appropriate to briefly mention the ethical violations that are alluded to (and cited) in the second paragraph.</p>
                <p>
                    <italic>-Details on the ethical violations of early tenofovir trials have been added.&#x00a0;</italic>
                </p>
                <p>3.&#x00a0;At the end of the background, it might be helpful to state that the purpose of the paper is not only to articulate the community engagement practices implemented in the projects but also to explicitly inform future work with appropriate community engagement/advise other investigators on how to do such work.</p>
                <p>
                    <italic>-A statement on the purpose of the paper has been added to the end of the Background section.&#x00a0;</italic>
                </p>
                <p>4.&#x00a0;The Partners PrEP description contains a somewhat confusing statement about how community entry was initiated by seeking government approval; what exactly was meant by this? &#x00a0;</p>
                <p>
                    <italic>-Thank you for pointing this out. The sentence has been edited to read: &#x201c;Approval for the project was initially sought from national and local government authorities in the Ministry of Health and Public Works, which was followed by meetings with lead members of community organizations (non-governmental, community-based, and faith-based), HIV serodiscordant couples support groups, and national and local health care authorities.&#x201d; Further details on the formation of the community advisory groups has also been added to the case study.&#x00a0;</italic>
                </p>
                <p>5.&#x00a0;Later in the same paragraph the authors say that &#x201c;site projects instituted CAGs&#x201d;; is this a typo that should have read &#x201c;project sites&#x201d;?</p>
                <p>
                    <italic>-Thank you for catching this. This has been corrected.</italic>
                </p>
                <p>6. When describing lessons learned, the Discussion mentions that special attention should be paid to handling &#x201c;crises&#x201d; in serodiscordant couples, but this concept was not really explained in the case studies themselves (except when mentioning that some couples faced &#x201c;challenges&#x201d; in Partners PrEP).</p>
                <p>
                    <italic>- We have removed this sentence as it has not been explored in the studies presented.</italic>
                </p>
            </body>
        </sub-article>
    </sub-article>
    <sub-article article-type="reviewer-report" id="report27497">
        <front-stub>
            <article-id pub-id-type="doi">10.21956/gatesopenres.14158.r27497</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Ndebele</surname>
                        <given-names>Paul</given-names>
                    </name>
                    <xref ref-type="aff" rid="r27497a1">1</xref>
                    <xref ref-type="aff" rid="r27497a2">2</xref>
                    <role>Referee</role>
                    <uri content-type="orcid">https://orcid.org/0000-0001-9669-1544</uri>
                </contrib>
                <aff id="r27497a1">
                    <label>1</label>Medical Research Council of Zimbabwe, Harare, Zimbabwe</aff>
                <aff id="r27497a2">
                    <label>2</label>The George Washington University, Washington, DC, USA</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>26</day>
                <month>7</month>
                <year>2019</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2019 Ndebele P</copyright-statement>
                <copyright-year>2019</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport27497" related-article-type="peer-reviewed-article" xlink:href="10.12688/gatesopenres.13042.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>reject</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>
                <list list-type="bullet">
                    <list-item>
                        <p>The authors state that their intention is to describe CE strategies and lessons learned.&#x00a0;Much of the paper reads like a progress report on recruitment and retention strategies.&#x00a0;CE is more than that.&#x00a0;The reader expects them to focus on strategies used, why they were selected, how useful the strategies were, and what the challenges associated with those selected strategies were.&#x00a0;They have not even succeeded in fully articulating the various roles of the communities in the various projects. What strategies did they employ to influence acceptance and community involvement?&#x00a0;The sections on South Africa, Kenya/Uganda and Nigeria&#x00a0;describe some specifics on strategies.&#x00a0;</p>
                    </list-item>
                    <list-item>
                        <p>The discussion section also focuses very much on recruitment and retention.&#x00a0;</p>
                    </list-item>
                    <list-item>
                        <p>The conclusion section focuses more on PrEP roll-out than on CE.&#x00a0;The topic could be edited to focus on community engagement strategies in PrEP demonstration projects.&#x00a0;</p>
                    </list-item>
                    <list-item>
                        <p>The sub-heading on "Assessment of the research projects&#x201d; is misleading as the section describes documentation of CE strategies/practices.</p>
                    </list-item>
                    <list-item>
                        <p>In the Table no sites are stated for Nigeria and some abbreviations are used for some implementers.&#x00a0;Based on what happened to previous HIV prevention trials, CE should therefore focus on acceptance and keeping communities updated about trials and addressing concerns and misconceptions/rumours.</p>
                    </list-item>
                </list>
            </p>
            <p>Does the article adequately reference differing views and opinions?</p>
            <p>Yes</p>
            <p>Are all factual statements correct, and are statements and arguments made adequately supported by citations?</p>
            <p>Yes</p>
            <p>Is the Open Letter written in accessible language?</p>
            <p>Yes</p>
            <p>Where applicable, are recommendations and next steps explained clearly for others to follow?</p>
            <p>No</p>
            <p>Is the rationale for the Open Letter provided in sufficient detail?</p>
            <p>No</p>
            <p>Reviewer Expertise:</p>
            <p>Community engagement, research ethics, public health</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to state that I do not consider it to be of an acceptable scientific standard, for reasons outlined above.</p>
        </body>
    </sub-article>
</article>
